JP2018033638A - Implant for medical use - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a novel implant for medical use, having excellent cell adhesion property or the like.SOLUTION: In an implant for medical use carrying ceramic particles, particle diameters of the ceramic particles are in the range of 10-700 nm, the ceramic particles are sintered particles of calcium phosphate, and the ceramic particles do not contain calcium carbonate. In the implant for medical use, the maximum diameter of the short axis in the particle diameters of the ceramic particles is 30 nm to 5 μm, the maximum diameter of the long axis therein is 75 nm to 10 μm, and the implant for medical use is configured with the sintered particles of calcium phosphate growing in the c axis direction and having an aspect ratio ((c axis length)/(a axis length)) of the crystal is 1-30.SELECTED DRAWING: None

Description

  The present invention relates to a novel medical implant.

  Conventionally, a medical implant carrying hydroxyapatite has been proposed as a medical implant from the viewpoint of good cell adhesion (for example, Patent Document 1).

  Here, when conventional HAp is used as a biomaterial, it is proposed to produce hydroxyapatite particles (ceramic particles) with high crystallinity by firing at a high temperature in order to reduce in vivo solubility and degradability. Has been. However, during this sintering, bonding occurs due to fusion between hydroxyapatite (HAp) particles (primary particles), resulting in irregular secondary particles in which the primary particles are bonded, resulting in a decrease in dispersibility and specific surface area. There was a problem.

  Therefore, in Patent Document 2, mixing is performed so that an anti-fusing agent is interposed between particles of primary particles made of ceramic raw material before sintering to form mixed particles, the mixed particles are sintered, and fusion is performed after the firing. A method for washing away the inhibitor has been proposed. According to the production method, ceramic particles having a high crystallinity and a small particle size can be obtained.

JP 2005-525165 A Japanese Patent No. 5043436

  Here, the present inventors have found that when the calcium phosphate sintered body described in Patent Document 2 is used for a medical implant, an undesirable event may occur from the viewpoint of biocompatibility and change in solubility. I found it. Therefore, a first object of the present invention is to provide a medical implant in which a decrease in biocompatibility and a change in solubility are suppressed as much as possible and a calcium phosphate sintered body particle having a smaller particle diameter is supported.

  Furthermore, the present inventors have found that the ceramic particles obtained by the production method of Patent Document 2 may not have sufficient cell adhesion when used for living organisms. Therefore, this invention makes it the 2nd subject to provide the medical implant which carry | supported the calcium-phosphate sintered compact particle | grains which show | played the outstanding cell adhesiveness.

  Next, the present inventors have found that the ceramic particles obtained by the production method of Patent Document 2 may not have sufficient dispersibility. When the dispersibility is low, aggregation or the like is caused, and as a result, an immune reaction can be caused in vivo, which is not preferable. Therefore, this invention makes it a 3rd subject to provide the medical implant which carry | supported the calcium-phosphate sintered compact particle | grains which show high dispersibility.

  The present inventor has intensively studied a method for obtaining a calcium phosphate sintered body particle group having a high degree of crystallinity and a small particle diameter and suitable for a medical implant introduced into the body, and as a result, calcium phosphate obtained by the above-described production method. The present invention has been completed with the knowledge that the sintered particle group includes a crystal phase of calcium carbonate, and further, the knowledge that the crystal phase of the calcium carbonate can reduce the biocompatibility expression and the like. .

The present invention (1) is a medical implant having ceramic particles at least partially supported thereon,
The particle size of the ceramic particles is in the range of 10 nm to 700 nm,
The ceramic particles are calcium phosphate sintered particles,
The ceramic particle is a medical implant characterized by not containing calcium carbonate.
The present invention (2) is the medical implant of the invention (1), wherein the ceramic particles are spherical.
The present invention (3) is a medical implant having ceramic particles supported at least in part,
The ceramic particles have a minor axis maximum diameter of 30 nm to 5 μm and a major axis of 75 nm to 10 μm, grow in the c-axis direction, and have an aspect ratio (c-axis length / a-axis length) of 1 ~ 30,
The ceramic particles are calcium phosphate sintered particles,
The ceramic particle is a medical implant characterized by not containing calcium carbonate.
The present invention (4) is the medical implant of the inventions (1) to (3), wherein the ceramic particles are hydroxyapatite sintered particles.
The present invention (5) is the medical implant according to any one of the inventions (1) to (4), wherein the ceramic particles do not contain an alkali metal element.
The present invention (6) is the medical implant according to any one of the inventions (1) to (5), wherein the ceramic particles include carbonate apatite on at least the surface thereof.
The present invention (7) is the medical implant according to any one of the inventions (1) to (6), wherein the ceramic particles satisfy the following property (A).
(A) After sufficiently drying, after being left for 3 days or more under conditions of atmospheric pressure, temperature 25 ° C., humidity 50%, thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR 6000) under a nitrogen stream at 10 ° C./min. The weight decreased in the temperature range of 25 to 200 ° C. is 2% or less.
In the present invention (8), in the ceramic particles, the half width at d = 2.814 measured by an X-ray diffraction method is in the range of 0.2 to 0.8. (7) A medical implant.

Here, as described later, in the present invention, “does not contain calcium carbonate” means that calcium carbonate is not substantially contained, and more specifically, the following criteria (1) to (3): It is to satisfy all.
(1) From the measurement result of X-ray diffraction, calcium carbonate is calcium carbonate (formula weight: 100.09) / hydroxyapatite (formula weight: 1004.62) = 0.1 / 99.9 (formula weight conversion ratio) or less. It is.
(2) In thermogravimetric differential thermal analysis (TG-DTA) measurement, a weight loss of 2% or more with a clear endotherm is not observed at 650 ° C to 800 ° C.
(3) In the FT-IR spectra obtained in the measurement Kubelka-Munk (KM) chart showing the calculated absorbance by the equation, separated peaks wavenumber appears between ^{860cm -1 ~890cm} -1, is attributed to calcium carbonate A peak around 877 cm ⁻¹ is not observed. The peak separation is performed by using, for example, software called fityk 0.9.4 under the conditions of Function Type: Gaussian and Fitting Method: Levenberg-Marquardt.

Further, in the present invention, when “does not contain calcium carbonate”, it is preferable that the following criterion (4) is further satisfied.
(4) When tested according to Quasi-drug raw material standard 2006 (hydroxyapatite), the amount of bubbles generated is 0.25 mL or less.

  In the present invention, “spherical” means that the aspect ratio of the particles is 1.35 or less (more preferably 1.25 or less, and still more preferably 1.2 or less). Here, the aspect ratio of the particles refers to a numerical value obtained by the following method. In the SEM image obtained by photographing the particle, two line segments are drawn on the particle so that both ends thereof are located on the outer periphery of the particle. At this time, the length of one line segment is the maximum. Further, the other line segment is drawn so as to be orthogonal to each other at the midpoint of the line segment. Of the two line segments drawn in this manner, the length of the shorter line segment is defined as the minor axis, the length of the longer line segment is defined as the major axis, and the ratio of major axis / minor axis is obtained. However, particles whose outlines are blurred, particles that are too close to another particle and whose boundary is ambiguous, particles that are partially hidden behind other particles, and the like are excluded from the measurement target.

  In the present invention, the “ceramic particle group” including “ceramic particles having a certain property” means that the “ceramic particles having a certain property” is 50% by mass or more based on the entire “ceramic particle group”. The content is preferably 70% by mass or more, and more preferably 90% by mass or more.

  ADVANTAGE OF THE INVENTION According to this invention, it becomes possible to provide the implant excellent in cell adhesiveness etc.

FIG. 1-1 is a chart showing the results of X-ray diffraction measurement of hydroxyapatite (HAp) sintered particles obtained in Example 1-1. FIG. 1-2 is a chart showing the results of X-ray diffraction measurement of hydroxyapatite (HAp) sintered particles obtained in Example 1-2. 1-3 is a chart showing the results of X-ray diffraction measurement of the hydroxyapatite (HAp) sintered body particles obtained in Comparative Example 1-1. FIG. 1-4 is a SEM photograph of the hydroxyapatite (HAp) sintered body particle group obtained in Example 1-1. FIG. 1-5 is a SEM photograph of the hydroxyapatite (HAp) sintered body particle group obtained in Example 1-1. 1-6 is a SEM photograph of a hydroxyapatite (HAp) sintered body particle group obtained in Example 1-2. FIG. 1-7 is a SEM photograph of the hydroxyapatite (HAp) sintered body particle group obtained in Example 1-2. FIG. 1-8 is a SEM photograph of a test material manufactured using the hydroxyapatite sintered body particle group according to Example 1-1. FIG. 1-9 is a SEM photograph of a test material manufactured using the hydroxyapatite sintered body particle group according to Example 1-2. FIG. 1-10 is an SEM photograph of a test material manufactured using the hydroxyapatite sintered body particle group according to Comparative Example 1-1. FIG. 1-11 is a dyed image of a test material produced using the hydroxyapatite sintered body particle group according to Example 1-1. FIG. 1-12 is a dyed image of a test material produced using the hydroxyapatite sintered body particle group according to Example 1-2. 2-1 is the result of the thermogravimetric differential thermal analysis (TG-DTA) measurement of the hydroxyapatite (HAp) fired body particle group according to Example 2-1. 2-2 is the result of the thermogravimetric differential thermal analysis (TG-DTA) measurement of the hydroxyapatite (HAp) fired body particle group according to Comparative Example 2-1. FIG. 2-3 is a chart showing the absorbance obtained by calculating the spectrum obtained in the FT-IR measurement by the Kubelka-Munk (KM) equation. In producing the hydroxyapatite (HAp) particles of Example 2-1, how the amount of calcium carbonate is changed by the pickling process is examined. The left chart in FIG. 2-3 shows hydroxyapatite (HAp) particles that have not been pickled, and the right chart in FIG. 2-3 shows hydroxyapatite particles that have been pickled. FIG. 2-4 is a chart showing an FT-IR spectrum of the hydroxyapatite (HAp) sintered body particles obtained in Example 2-1. FIG. 2-5 is a chart showing an FT-IR spectrum of hydroxyapatite (HAp) sintered particles obtained in Example 2-2. FIG. 2-6 is a SEM photograph of the hydroxyapatite (HAp) sintered body particle group obtained in Example 2-1. FIG. 2-7 is a SEM photograph of the hydroxyapatite (HAp) sintered body particle group obtained in Example 2-1. FIG. 2-8 is a SEM photograph of the hydroxyapatite (HAp) sintered body particle group obtained in Example 2-2. FIG. 2-9 is a SEM photograph of the hydroxyapatite (HAp) sintered body particle group obtained in Example 2-2. FIG. 2-10 is an SEM photograph of a test material produced using the hydroxyapatite (HAp) sintered body particle group according to Example 2-1. Cell adhesion was evaluated. FIG. 2-11 is a SEM photograph of a test material produced using a hydroxyapatite (HAp) sintered body particle group according to Example 2-2. Cell adhesion was evaluated. FIG. 2-12 is an SEM photograph of a test material manufactured using a hydroxyapatite (HAp) sintered body particle group according to Comparative Example 2-1. Cell adhesion was evaluated.

≪Medical implant≫
The medical implant according to the present invention is a medical implant in which ceramic particles are supported at least in part. Here, the “medical implant” is a general term for instruments implanted in the body. For example, dental implants (artificial roots), orthopedic implants (for example, artificial hip joints, artificial knee joints, artificial finger joints, artificial vertebral bodies, bolts, pins and screws for fixing bones in the treatment of fractures, rheumatism, etc. ). In addition, it does not specifically limit as a presence form of a ceramic particle, It includes any aspect of adhering to the surface of an implant, embedding in an implant, or kneading into a material. The ceramic particles may be directly supported, or may be indirectly supported by attaching a member supporting ceramic particles. Hereinafter, a medical implant carrying ceramic particles will be described in detail, and then a method for producing the medical implant will be described.

<A-1. Ceramic particles>
The main feature of the present invention is that, in a group of ceramic particles including ceramic particles, the ceramic particles have a minute size and “do not contain calcium carbonate”. In addition, the present inventors have found two types of production methods as a method for obtaining such a group of ceramic particles. Therefore, in the following, the first manufacturing method and the second manufacturing method will be broadly described. Among these, the 1st manufacturing method can achieve a severer standard in the standard "it does not contain calcium carbonate". The “ceramic particle group” may be read as “ceramic particles”.

<<< First Manufacturing Method >>>
Hereinafter, the first manufacturing method of the calcium phosphate particle group according to the present invention will be described, and then the ceramic particle group obtained by the first manufacturing method will be described.

<< 1. First production method of ceramic particles >>
<1-1. Raw material>
Specific examples of calcium phosphate (CaP) that is a ceramic raw material before firing include hydroxyapatite (Ca ₁₀ (PO ₄ ) ₆ (OH) ₂ ), tricalcium phosphate (Ca ₃ (PO ₄ ) ₂ ), and calcium metaphosphate. (Ca (PO ₃ ) ₂ ), Ca ₁₀ (PO ₄ ) ₆ F ₂ , Ca ₁₀ (PO ₄ ) ₆ Cl _{2 and the} like. Here, the calcium phosphate (CaP) may be artificially produced by a known production method such as a wet method, a dry method, a hydrolysis method, or a hydrothermal method. Naturally derived ones obtained from the above may be used.

<1-2. Process>
(1-1. Primary particle generation step)
Hereinafter, in the manufacturing method of the calcium phosphate particle group according to the present embodiment, the case where the primary particles are spherical and rod-shaped is exemplified, but the present invention is not limited to this, and primary particles having any shape that can be manufactured are applicable.

Primary particle generation process of spherical ceramic particles First, "primary particles" are particles formed of ceramic raw materials {calcium phosphate (CaP), hydroxyapatite (HAp), etc.} before sintering in the ceramic particle production process. Means that. That is, it means a particle formed for the first time in the production process of ceramic particles. In a narrow sense, it means single crystal particles. In the claims and specification, “primary particles” include those in an amorphous state, a low crystalline state, and those in a sintered body state after sintering. Meaning. On the other hand, “secondary particles” are a combination of multiple “primary particles” by physical bonds such as fusion, chemical bonds such as Van der Waals force, electrostatic interaction, or covalent bonds. It means a particle in a state of being formed. In particular, the number of bonds between primary particles, the shape after bonding, and the like are not limited, and mean all bonded two or more primary particles. In particular, the “single crystal primary particle” means a primary particle made of a single crystal of a ceramic raw material or a particle lump in which the primary particles made of the single crystal are assembled by ionic interaction. The “particle aggregate assembled by ionic interaction” is a particle aggregate that self-assembles by ionic interaction when dispersed in a medium containing water or an organic solvent. It does not contain secondary particles that are melted and polycrystallized.

  The primary particle generation step is known per se and is not particularly limited as long as it is a step capable of generating the primary particles, and may be appropriately selected depending on the ceramic raw material to be manufactured. For example, if phosphoric acid is dropped into a calcium hydroxide slurry at room temperature, calcium phosphate (CaP) particles are precipitated.

  The method for producing a ceramic particle group according to the present embodiment is a method for producing a ceramic particle group by sintering the primary particle group composed of the primary particles produced by the primary particle production step while preventing fusion or the like. . Therefore, the state (particle size, particle size distribution) of the primary particles generated by the primary particle generation step is directly reflected in the state (particle size, particle size distribution) of the ceramic particles as the final product. Therefore, in the case of producing a ceramic particle group having a fine particle size (nanometer size) and a uniform particle size (narrow particle size distribution), the particle size is fine (nanometer size) in the primary particle generation step. ) And a uniform particle size (narrow particle size distribution) must be generated.

  In this case, the primary particle size (average particle size and particle size distribution) is preferably 10 nm to 700 nm, more preferably 15 nm to 450 nm, and most preferably 20 nm to 400 nm. Further, the coefficient of variation of the particle diameter of the primary particle group composed of primary particles is preferably 20% or less, more preferably 18% or less, and most preferably 15% or less. The particle diameter and coefficient of variation of the primary particles may be calculated by measuring the particle diameter of at least 100 primary particles using a dynamic light scattering method or an electron microscope.

  The “variation coefficient” is a value indicating the variation in particle diameter between particles that can be calculated by standard deviation ÷ average particle diameter × 100 (%).

  There is no particular limitation on the method of generating the primary particle group that is fine (nanometer size) and has a uniform particle size (narrow particle size distribution) as described above. For example, JP 2002-137910 A No. 5044336, Journal of Nanoscience and Nanotechnology Vol. 7, 848-851, 2007.

  In addition, this step may include a step of washing the generated primary particles with water or the like, and a step of collecting the primary particles by centrifugation, filtration, or the like.

-Primary particle production process of rod-shaped ceramic particles Rod-shaped ceramic particles {particle diameter is 30 nm to 5 μm, the longest axis is 75 nm to 10 μm, and the major axis is 75 nm to 10 μm. The primary particle production step of the ceramic particles whose ratio (c-axis length / a-axis length) is 1 to 30 is known per se, for example, JP 2002-137910 A, Journal of Nanoparticle Research (2007). 9: 807-815.

  In addition, this step may include a step of washing the generated primary particles with water or the like, and a step of collecting the primary particles by centrifugation, filtration, or the like.

(Freezing process)
The freezing step is a step of freezing the aqueous medium containing calcium phosphate (CaP) before sintering. Here, the aqueous medium is a liquid medium containing water as a main component (preferably 90% by mass or more based on the total mass of the liquid medium). Preferably, only water is used, and a liquid miscible with water (alcohol or the like) may be appropriately added. In addition, a solution for producing calcium phosphate (CaP) as primary particles, that is, a solution obtained by dissolving a phosphate source and a calcium source in water may be frozen as it is. Here, the freezing temperature is not particularly limited, but is preferably −1 to −269 ° C. More preferably, it is −5 to −196 ° C. The freezing time is not particularly limited, but is preferably 1 minute to 24 hours.

(Thawing process)
The thawing step is a step in which the frozen body obtained in the freezing step is placed at a temperature exceeding the melting point of the aqueous medium of the frozen body to melt the aqueous medium.

(Separation process)
The separation step is a step of separating calcium phosphate from the aqueous medium containing calcium phosphate melted in the thawing step. The separation method may be a method of collecting the precipitate after thawing, or a method of collecting by centrifugation.

(Baking process)
The said sintering process is a process which exposes the calcium-phosphate primary particle composition obtained by the said isolation | separation process to sintering temperature, and makes the primary particle contained in the said composition a ceramic particle (sintered body particle). Although the reason is not clear, even when the anti-fusing agent as in Patent Document 1 is not used, when the above freeze / thaw process is obtained and fired, it is exposed to high temperature conditions in the sintering process. Also, it is possible to prevent fusion between primary particles. Here, the sintering temperature in the sintering step may be appropriately set so that the crystallinity of the ceramic particles has a desired hardness, and for example, 300 to 1000 ° C. is suitable. Moreover, 1-20 degrees C / min is suitable for the temperature increase rate in the said sintering process, for example. Furthermore, the sintering time in the sintering step may be appropriately set based on the hardness of the ceramic particles and the like, and for example, 0.5 to 3 hours is preferable. In addition, the apparatus etc. which are used for the said sintering process are not specifically limited, What is necessary is just to employ | adopt after selecting a commercially available baking furnace suitably according to a manufacturing scale, manufacturing conditions, etc.

(Crushing process)
The pulverization step is a step of pulverizing the aggregate after the sintering step to obtain a calcined calcium phosphate particle group having a desired size. Here, normally, the fired body that has been made into secondary particles can hardly be reduced to the size of the primary particles even if a considerable pulverization step is performed. On the other hand, according to the method of the present embodiment, it is possible to easily pulverize to the primary particle size level even with a simple pulverization process. Here, the pulverization method is not particularly limited, and examples thereof include ultrasonic treatment and pulverization using a pulverized sphere. After the pulverization treatment, particles having a smaller diameter may be collected by removing unpulverized ones.

(Washing process)
The washing step is a component other than the calcined calcium phosphate particles, for example, impurities derived from raw materials used in producing the primary particles of calcium phosphate (for example, calcium or phosphate-derived impurities not involved in calcium phosphate formation, nitric acid or ammonium-derived This is a step of cleaning the impurities. It is preferable to wash with water. In the case of hydroxyapatite (HAp) sintered body particles, the hydroxyapatite (HAp) sintered body particles are easily dissolved under the condition of pH less than 4.0, and therefore the removal step is performed at pH 4.0 to pH 12.0. Is preferred. Moreover, this order does not ask | require, such as performing a grinding | pulverization process and a washing | cleaning process alternately.

(Drying process)
A drying process is a process of removing a solvent by heating etc. after the said grinding | pulverization process or the said washing | cleaning process, and obtaining a calcium-phosphate particle group. The drying method is not particularly limited.

(Endotoxin removal step)
Here, in this step, an endotoxin removal step may be provided as necessary.

  An endotoxin removal process is a process performed by heating at 300 degreeC by the normal pressure under air, for example. The calcined calcium phosphate is preferably subjected to water washing in the washing step described above after firing. At this time, the calcined calcium phosphate adsorbs endotoxin that is slightly present in the environment such as in water, in a storage container or in a handling atmosphere. Here, this endotoxin is a harmful substance, and remaining in the calcined calcium phosphate is unsuitable particularly when the calcined calcium phosphate is used as a biomaterial. Therefore, the said process is implemented and the adsorbed endotoxin is decomposed | disassembled. In addition, you may perform the said endotoxin removal process combining the drying process mentioned above.

  Here, the present inventors have found that when the calcium phosphate calcined body obtained by the conventional production method is subjected to the heat treatment, the original particle size may be doubled or more. In particular, such an increase in particle size is an undesirable phenomenon when the calcium phosphate fired body is used for applications where a finer particle size is required. On the other hand, although the reason is not clear, the calcined calcium phosphate obtained according to the first production method hardly changes in particle size even when heated at 300 ° C. to remove endotoxin. Therefore, according to this production method, it is also possible to obtain a calcium phosphate sintered body particle group having a smaller particle size from which endotoxin has been removed.

  Here, according to this production method, unlike the prior art, fine calcium phosphate sintered particles can be produced without using an anti-fusing agent such as a polymer compound or a metal salt. More specifically, according to this production method, an anti-fusing agent containing a polymer compound or a different metal element (for example, an alkali metal element, an alkaline earth metal element other than calcium, a transition metal element, etc.) in the production process is provided. Compared with the conventional manufacturing method used for a manufacturing raw material, it becomes possible to obtain the calcium-phosphate sintered compact particle | grains which improved crystallinity more (thus, it is hard to melt | dissolve).

<< 2. Calcium phosphate sintered body particle group obtained by the first production method >>
<2-1. Spherical Calcium Phosphate Sintered Particle Group>
The spherical calcium phosphate sintered body particle group obtained by this production method is a ceramic particle group containing spherical ceramic particles, the particle diameter of the ceramic particles is in the range of 10 nm to 700 nm, and the ceramic particles are This is a ceramic particle group that is a calcium phosphate sintered body particle and that the ceramic particle group does not substantially contain calcium carbonate.

  Furthermore, the spherical calcium phosphate sintered body particle group obtained by this production method preferably has a coefficient of variation of the particle diameter of the ceramic particle group of 30% or less, preferably 25% or less, It is particularly preferable that it is 20% or less. The ceramic particle group is a fine particle and a uniform particle size (narrow particle size distribution). Therefore, there is an effect that it can be more uniformly adsorbed to the medical polymer material without performing an additional operation such as a particularly advanced classification. And since it does not contain calcium carbonate, when using as a biomaterial, it becomes possible to prevent the situation from which the biocompatibility and solubility of a material change.

  Further, from another aspect, the spherical calcium phosphate sintered body particle group obtained by the present production method is a ceramic particle group including spherical ceramic particles, and is composed of primary particles composed of a single crystal, or primary particles composed of the single crystal. When a particle lump in which particles are aggregated by ionic interaction is a single crystal primary particle, the ratio of the single crystal primary particles contained in the ceramic particle group occupies a majority, and the ceramic particles are sintered calcium phosphate particles. The ceramic particle group is characterized in that the ceramic particle group does not contain calcium carbonate. The ceramic particle group is a primary particle composed of a single crystal having a superior dispersibility in a solvent, or a particle lump in which the primary particles composed of the single crystal are assembled by ionic interaction (single crystal primary particles). Exist as. Therefore, there is an effect that the adsorption to the medical polymer base material described above is facilitated. Moreover, since there is no coupling | bonding of primary particles, a specific surface area is high. Furthermore, since it is highly stable in vivo and excellent in dispersibility, it has an effect that it can be used as a medical material capable of carrying and sustained release of a drug. And since it does not contain calcium carbonate, when used as a biomaterial, the biocompatibility of the material and the original solubility of calcium phosphate are maintained. In this way, a particle lump in which primary particles made of a single crystal are aggregated by ionic interaction may be used as ceramic particles.

  Further, in the ceramic particle group, the ratio of the single crystal primary particles contained in the ceramic particle group may be 70% or more. By adopting such a configuration, there is an effect that the adsorption to the medical polymer base material is facilitated.

  Moreover, the ceramic particle group may have a particle diameter of the ceramic particles in a range of 10 nm to 700 nm. According to the said structure, there exists an effect that it can adsorb | suck more uniformly with respect to medical polymeric material.

  The ceramic particle group may have a coefficient of variation of the particle diameter of the ceramic particle group of 20% or less. By adopting this configuration, there is an effect that it can be more uniformly adsorbed to the medical polymer material without performing an additional operation such as particularly high classification.

  The ceramic particles may be hydroxyapatite sintered particles. The particles are composed of a hydroxyapatite sintered body that has higher biocompatibility and can be used for a wide range of applications. Therefore, it is particularly preferable as a medical material.

  Further, the ceramic particle group was washed with water, and heated at 300 ° C. under atmospheric pressure in the air after the water washing, based on the particle diameter of the ceramic particle group after the water washing. The change rate of the particle diameter at the time may be ± 20%.

<2-2. Rod-like Calcium Phosphate Sintered Particle Group>
The rod-shaped calcium phosphate sintered body particle group obtained by this production method is a ceramic particle group containing ceramic particles, and the particle diameter of the ceramic particles is such that the maximum diameter of the short axis is 30 nm to 5 μm, and the long axis is 75 nm to 10 μm, growing in the c-axis direction, and having a crystal aspect ratio (c-axis length / a-axis length) of 1 to 30, wherein the ceramic particles are calcium phosphate sintered particles, The ceramic particle group does not contain calcium carbonate.

  Since the rod-shaped calcium phosphate baked particles have a much larger area for adhesion than conventional fine particles, the adhesion to the polymer base material can be improved, so that the surface of the polymer such as biocompatible medical materials such as catheters can be improved. Suitable for modification. In addition, since it does not contain calcium carbonate, it is possible to prevent a situation where carbon dioxide gas is generated from the material when used as a biomaterial. As a method for modifying the polymer surface, an active group of calcium phosphate (for example, hydroxyapatite nanoparticles) and a polymer substrate, for example, a silicone rubber obtained by graft polymerization of a vinyl polymerizable monomer having a carboxyl group on the surface , A method of chemically reacting with an active group, a method of using a curable adhesive, a method of heating a polymer substrate to near the melting point and embedding it in the substrate, etc. The same applies to the spherical calcium phosphate sintered body particle group). The rod shape may be a truncated columnar structure with a tip angle having an oblique surface.

  The ceramic particles may be hydroxyapatite sintered particles. The particles are composed of a hydroxyapatite sintered body that has higher biocompatibility and can be used for a wide range of applications. Therefore, it is particularly preferable as a medical material.

  Further, the ceramic particle group was washed with water, and heated at 300 ° C. under atmospheric pressure in the air after the water washing, based on the particle diameter of the ceramic particle group after the water washing. The change rate of the particle diameter at the time may be ± 20%.

<2-3. Properties>
Next, the property of the calcium phosphate sintered body particle group obtained by the manufacturing method according to this embodiment will be described.

  According to this form, it becomes possible to make it the fine calcium-phosphate sintered compact particle group which does not contain calcium carbonate.

  By not containing calcium carbonate, it becomes possible to obtain calcium phosphate sintered body particles in which a decrease in biocompatibility and a change in solubility are suppressed.

  Furthermore, according to this embodiment, it is possible to form a fine calcium phosphate sintered body particle group that does not contain an alkali metal element.

  Further, by not containing an alkali metal element, it becomes possible to obtain calcium phosphate sintered body particles that are further improved in crystallinity, are hardly dissolved, and are excellent in cell adhesion.

Here, “does not contain calcium carbonate” means that calcium carbonate is not substantially contained, and does not necessarily exclude trace amounts, but satisfies the following criteria (1) to (3): It is preferable to satisfy the criterion (4).
(1) From the measurement result of X-ray diffraction, calcium carbonate is calcium carbonate (formula weight: 100.09) / hydroxyapatite (formula weight: 1004.62) = 0.1 / 99.9 (formula weight conversion ratio) or less. It is.
(2) In thermogravimetric differential thermal analysis (TG-DTA) measurement, a weight loss of 2% or more with a clear endotherm is not observed at 650 ° C to 800 ° C.
(3) In the FT-IR spectra obtained in the measurement Kubelka-Munk (KM) chart showing the calculated absorbance by the equation, separated peaks wavenumber appears between ^{860cm -1 ~890cm} -1, is attributed to calcium carbonate A peak around 877 cm ⁻¹ is not observed. The peak separation is performed by using, for example, software called fityk 0.9.4 under the conditions of Function Type: Gaussian and Fitting Method: Levenberg-Marquardt.
(4) When tested according to Quasi-drug raw material standard 2006 (hydroxyapatite), the amount of bubbles generated is 0.25 mL or less.

  Further, “not containing an alkali metal element” means that the alkali metal element is not substantially contained. With respect to each alkali metal element, the weight of the alkali metal element with respect to the total weight of the calcium phosphate sintered particles is 10 ppm or less ( It is preferably 1 ppm or less. In addition, a conventionally well-known method can be applied as an analysis method, for example, it may analyze by ICP-MS.

  Furthermore, as described above, according to this embodiment, it is possible to obtain a calcium phosphate sintered body particle group that does not contain an alkaline earth metal element other than calcium or a transition metal element.

  Thus, by containing substantially no alkaline earth metal elements other than calcium and transition metal elements, the crystallinity is further enhanced, the dissolution is difficult, and the calcium phosphate sintered body particles are excellent in cell adhesion. It becomes possible to do. Moreover, it becomes possible to improve the safety | security to a biological body substantially by not containing a transition metal element.

  Note that “not containing an alkaline earth metal element” (“not containing a transition metal element”) means, as described above, for each alkaline earth metal element (each transition metal element), It indicates that the weight of the alkaline earth metal element (transition metal element) with respect to the weight is 10 ppm or less (preferably 1 ppm or less). In addition, a conventionally well-known method can be applied as an analysis method, for example, it may analyze by ICP-MS.

Here, the calcium phosphate particle group obtained by this production method further has the following property (A) as moisture adsorptivity.
(A) After sufficiently drying (for example, after drying for 18 hours or more under normal pressure, temperature 60 ° C., humidity 45-85%), under normal pressure, temperature 25 ° C., humidity 50% After being allowed to stand for 3 days or longer, a thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR6000) under a nitrogen stream at 10 ° C./min. The weight decreased in the temperature range of 25 to 200 ° C. is 2% or less.

  It has been found that the cell adhesion can be further improved by the calcium phosphate particle group satisfying such properties.

  Moreover, it is suitable for the calcination calcium phosphate particle group in this form that the half value width in d = 2.814 measured by X ray diffraction method (XRD) satisfy | fills 0.2-0.8, 0 It is more preferable to satisfy 3 to 0.7. By setting the half width of the calcined calcium phosphate particle group within this range, the solubility can be further reduced and the cell adhesion can be further improved.

  In the adjustment of the half width, the firing temperature and the firing time may be adjusted as appropriate. When the half width is desired, for example, the firing temperature (maximum temperature reached) is set to 600 to 800 ° C. The holding time may be set to 0 to 1 h or the like.

<<< Second Manufacturing Method >>>
Hereinafter, the second manufacturing method of the calcium phosphate particle group according to the present invention will be described, and then the ceramic particle group obtained by the second manufacturing method will be described.

<< 1. Second production method for ceramic particles >>
<1-1. Raw material>
Specific examples of calcium phosphate (CaP) that is a ceramic raw material before firing include hydroxyapatite (Ca ₁₀ (PO ₄ ) ₆ (OH) ₂ ), tricalcium phosphate (Ca ₃ (PO ₄ ) ₂ ), and calcium metaphosphate. (Ca (PO ₃ ) ₂ ), Ca ₁₀ (PO ₄ ) ₆ F ₂ , Ca ₁₀ (PO ₄ ) ₆ Cl _{2 and the} like. Here, the calcium phosphate (CaP) may be artificially produced by a known production method such as a wet method, a dry method, a hydrolysis method, or a hydrothermal method. Naturally derived ones obtained from the above may be used.

<1-2. Process>
The method for producing a ceramic particle group according to the present embodiment may include at least a “mixing step”, a “sintering step”, and a “pickling step”, but other steps (for example, “primary particle generation step”). ”,“ Removal step ”,“ pulverization step ”,“ drying step ”and the like.

  For example, the manufacturing method of the ceramic particle group according to the present embodiment is performed in the order of “1. primary particle generation process” → “2. Mixing process” → “3. Sintering process” → “4. Pickling process”. .

(Primary particle generation process)
Hereinafter, in the manufacturing method of the calcium phosphate particle group according to the present embodiment, the case where the primary particles are spherical and rod-shaped is exemplified, but the manufacturing method of the present embodiment is not limited thereto, and the primary particles can be manufactured. It can be any shape.

Primary particle generation process of spherical ceramic particles First, "primary particles" are particles formed of ceramic raw materials {calcium phosphate (CaP), hydroxyapatite (HAp), etc.} before sintering in the ceramic particle production process. Means that. That is, it means a particle formed for the first time in the production process of ceramic particles. In a narrow sense, it means single crystal particles. In the claims and specification, “primary particles” include those in an amorphous state, a low crystalline state, and those in a sintered body state after sintering. Meaning. On the other hand, “secondary particles” are a combination of multiple “primary particles” by physical bonds such as fusion, chemical bonds such as Van der Waals force, electrostatic interaction, or covalent bonds. It means a particle in a state of being formed. In particular, the number of bonds between primary particles, the shape after bonding, and the like are not limited, and mean all bonded two or more primary particles. In particular, the “single crystal primary particle” means a primary particle made of a single crystal of a ceramic raw material or a particle lump in which the primary particles made of the single crystal are assembled by ionic interaction. The “particle aggregate assembled by ionic interaction” is a particle aggregate that self-assembles by ionic interaction when dispersed in a medium containing water or an organic solvent. It does not contain secondary particles that are melted and polycrystallized.

  The primary particle generation step is known per se and is not particularly limited as long as it is a step capable of generating the primary particles, and may be appropriately selected depending on the ceramic raw material to be manufactured. For example, if phosphoric acid is dropped into a calcium hydroxide slurry at room temperature, calcium phosphate (CaP) particles are precipitated.

  The method for producing a ceramic particle group according to the present embodiment is a method for producing a ceramic particle group by sintering the primary particle group composed of the primary particles produced by the primary particle production step while preventing fusion or the like. . Therefore, the state (particle size, particle size distribution) of the primary particles generated by the primary particle generation step is directly reflected in the state (particle size, particle size distribution) of the ceramic particles as the final product. Therefore, in the case of producing a ceramic particle group having a fine particle size (nanometer size) and a uniform particle size (narrow particle size distribution), the particle size is fine (nanometer size) in the primary particle generation step. ) And a uniform particle size (narrow particle size distribution) must be generated.

  In this case, the primary particle size (average particle size and particle size distribution) is preferably 10 nm to 700 nm, more preferably 15 nm to 450 nm, and most preferably 20 nm to 400 nm. Further, the coefficient of variation of the particle diameter of the primary particle group composed of primary particles is preferably 20% or less, more preferably 18% or less, and most preferably 15% or less. The particle diameter and variation coefficient of the primary particles may be calculated by measuring the particle diameter of at least 100 primary particles using dynamic light scattering or an electron microscope.

  The “variation coefficient” is a value indicating the variation in particle diameter between particles that can be calculated by standard deviation ÷ average particle diameter × 100 (%).

  There is no particular limitation on the method of generating the primary particle group that is fine (nanometer size) and has a uniform particle size (narrow particle size distribution) as described above. For example, JP 2002-137910 A And the method described in Japanese Patent No. 5044336, Journal of Nanoscience and Nanotechnology 7, 848-851, 2007.

  In addition, this step may include a step of washing the generated primary particles with water or the like, and a step of collecting the primary particles by centrifugation, filtration, or the like.

-Primary particle production process of rod-shaped ceramic particles Rod-shaped ceramic particles {particle diameter is 30 nm to 5 μm, the longest axis is 75 nm to 10 μm, and the major axis is 75 nm to 10 μm. The primary particle production step of the ceramic particles having a ratio (c-axis length / a-axis length) of 1 to 30 is known per se, for example, JP 2002-137910 A, Journal of Nanoparticle Research 9, 807. -815, 2007 can be mentioned.

  In addition, this step may include a step of washing the generated primary particles with water or the like, and a step of collecting the primary particles by centrifugation, filtration, or the like.

(Mixing process)
The mixing step is a step of mixing the primary particles and the anti-fusing agent. By interposing an anti-fusing agent between the particles of the primary particle group obtained by the primary particle generation step, it is possible to prevent the fusion of primary particles in the subsequent sintering step. It is. The mixture of primary particles and anti-fusing agent obtained by the mixing step is referred to as “mixed particles”.

  Here, the “fusion preventive agent” is not particularly limited as long as it can prevent fusion between primary particles, but may be non-volatile at a sintering temperature in a subsequent sintering step. preferable. Because it is non-volatile under the sintering temperature condition, it does not disappear from the primary particles during the sintering process, and the fusion of the primary particles can be reliably prevented. However, it is not necessary to have 100% non-volatility at the sintering temperature, as long as it is non-volatile so that 10% or more remains between the primary particles after the sintering process is completed. The anti-fusing agent may be chemically decomposed by heat after completion of the sintering process. That is, if it remains after the end of the sintering process, it is not necessary to be the same substance (compound) before and after the start of the sintering process.

  The anti-fusing agent is preferably a substance that dissolves in a solvent, particularly an aqueous solvent. As described above, by using an anti-fusing agent that dissolves in a solvent as an anti-fusing agent, the ceramic particles containing the anti-fusing agent can be fused only by suspending them in an aqueous solvent such as pure water. Inhibitors (such as calcium carbonate) can be removed. In particular, if the anti-fusing agent is soluble in an aqueous solvent, it is not necessary to use an organic solvent to remove the anti-fusing agent. It becomes. Therefore, it can be said that the anti-fusing agent can be removed from the ceramic particle group more easily. Although it does not specifically limit as said solvent, For example, water, ethanol, methanol etc. are mentioned as an aqueous solvent, Acetone, toluene etc. are mentioned as an organic solvent.

  The aqueous solvent may contain a chelate compound such as oxalate, ethylenediamine, bipyridine, and ethylenediaminetetraacetate in order to increase the solubility of the anti-fusing agent in water. Further, the aqueous solvent may contain electrolyte ions such as sodium chloride, ammonium nitrate and potassium carbonate in order to increase the solubility of the anti-fusing agent in water.

  Here, it can be said that the higher the solubility of the anti-fusing agent in the solvent is, the higher the removal efficiency becomes. The preferable solubility is preferably 0.01 g or more, more preferably 1 g or more, and most preferably 10 g or more, when the amount of solute (g) with respect to 100 g of solvent is the solubility.

  Specific examples of the anti-fusing agent include calcium chloride, calcium oxide, calcium sulfate, calcium nitrate, calcium carbonate, calcium hydroxide, calcium acetate, calcium citrate, and other calcium salts (or complexes), potassium chloride, potassium oxide. Potassium salts such as potassium sulfate, potassium nitrate, potassium carbonate, potassium hydroxide and potassium phosphate, sodium salts such as sodium chloride, sodium oxide, sodium sulfate, sodium nitrate, sodium carbonate, sodium hydroxide and sodium phosphate It is done.

  The method of mixing the primary particles and the anti-fusing agent in the mixing step is not particularly limited, and after mixing the solid anti-fusing agent with the solid primary particles, the mixture is mixed using a blender. Or a method of dispersing primary particles in a solution of an anti-fusing agent. However, since it is difficult to uniformly mix the solid and the solid, it can be said that the latter is a preferable method for interposing the anti-fusing agent uniformly and reliably between the primary particles. When the latter method is adopted, it is preferable to dry the anti-fusing agent solution in which primary particles are dispersed. This is because the state where the primary particles and the anti-fusing agent are uniformly mixed can be maintained over a long period of time. Also in the Example mentioned later, the hydroxyapatite (HAp) primary particle 0.5g is disperse | distributed to calcium carbonate saturated aqueous solution, It is made to dry at 80 degreeC, and the mixed particle is acquired.

  In the mixing step, a solution containing a polymer compound having any of a carboxyl group, a sulfate group, a sulfonic acid group, a phosphoric acid group, a phosphonic acid group or an amino group in the side chain is mixed with the primary particles, It may be a step of further adding a metal salt (alkali metal salt and / or alkaline earth metal salt and / or transition metal salt). By adopting the above steps, the polymer compound adsorbs on the surface of hydroxyapatite (HAp), so that contact between hydroxyapatite (HAp) in the anti-fusing agent mixing process can be surely prevented, and then calcium By adding the salt, the anti-fusing agent can be reliably deposited on the surface of hydroxyapatite (HAp). In the following description, a polymer compound having any of a carboxyl group, a sulfate group, a sulfonic acid group, a phosphoric acid group, a phosphonic acid group or an amino group in the side chain is simply referred to as “polymer compound”. .

  The polymer compound is not particularly limited as long as it is a compound having any of a carboxyl group, a sulfate group, a sulfonic acid group, a phosphoric acid group, a phosphonic acid group, or an amino group in the side chain. For example, examples of the polymer compound having a carboxyl group in the side chain include polyacrylic acid, polymethacrylic acid, carboxymethyl cellulose, styrene-maleic anhydride copolymer, and the like, as a polymer compound having a sulfate group in the side chain. And polyacrylic acid alkyl sulfate, polymethacrylic acid alkyl sulfate, polystyrene sulfuric acid and the like. Examples of the polymer compound having a sulfonic acid group in the side chain include polyacrylic acid alkyl sulfonic acid ester, polymethacrylic acid alkyl sulfone. Examples of the polymer compound having a phosphate group in the side chain include polyacrylic acid alkyl phosphate ester, polymethacrylic acid alkyl phosphate ester, polystyrene phosphoric acid, polyacryloylaminomethylphosphonic acid. Etc. Examples of the polymer compound having a phosphonic acid group in the side chain include polyacrylic acid alkylphosphonic acid ester, polymethacrylic acid alkylphosphonic acid ester, polystyrene phosphonic acid, polyacryloylaminomethylphosphonic acid, and polyvinylalkylphosphonic acid. Examples of the polymer compound having an amino group in the side chain include polyacrylamide, polyvinylamine, polymethacrylic acid aminoalkyl ester, polyaminostyrene, polypeptide, protein and the like. In the mixing step, any one of the above polymer compounds may be used, but a plurality of types of polymer compounds may be mixed and used.

  The molecular weight of the polymer compound is not particularly limited, but is preferably 100 g / mol or more and 1,000,000 g / mol or less, more preferably 500 g / mol or more and 500,000 g / mol or less, and 1,000 g / mol or less. Most preferably, it is at least mol but not more than 300,000 g / mol. If the ratio is less than the above preferable range, the ratio of entering between the primary particles decreases, and the ratio of preventing contact between the primary particles decreases. On the other hand, when the above preferred range is exceeded, the solubility of the polymer compound becomes low, and the operability such as increase in the viscosity of the solution containing the polymer compound becomes unfavorable.

  The solution containing the polymer compound is preferably an aqueous solution. This is because the hydroxyapatite (HAp) sintered body particles are dissolved under strong acidic conditions. The pH of the aqueous solution containing the polymer compound is not particularly limited as long as the pH is 5 or more and 14 or less and the HAp particles are insoluble. The aqueous solution containing the polymer compound may be prepared by dissolving the polymer compound in distilled water, ion-exchanged water or the like, and adjusting the pH with an aqueous solution of ammonia, sodium hydroxide, potassium hydroxide or the like.

  The concentration of the polymer compound contained in the aqueous solution is preferably 0.001% w / v or more and 50% w / v or less, more preferably 0.005% w / v or more and 30% w / v or less. Most preferred is 01% w / v or more and 10% w / v or less. When the amount is less than the above preferable range, the amount of entering between the primary particles is small, and the ratio of preventing contact between the primary particles is low. On the other hand, when the above preferred range is exceeded, it is not preferable because dissolution of the polymer compound becomes difficult and operability such as increase in the viscosity of the solution containing the polymer compound becomes worse.

  In the mixing step in this embodiment, a solution containing the polymer compound and primary particles are mixed. Such mixing may be performed by, for example, adding primary particles into the solution and dispersing the primary particles by a stirring operation or the like. By such an operation, in the method for producing a ceramic particle group according to the present embodiment, the polymer compound is adsorbed on the surface of the primary particle, and a carboxyl group, a sulfate group, a sulfonic acid group, a phosphoric acid group, a phosphonic acid group or an amino group is adsorbed. Either can be added to the surface of the primary particles. At this time, the carboxyl group, sulfuric acid group, sulfonic acid group, phosphoric acid group, phosphonic acid group or amino group is present in an ionic state in the solution.

Next, if a metal salt (alkali metal salt and / or alkaline earth metal salt and / or transition metal salt) is further added to the solution in which the polymer compound-containing solution and the primary particles are mixed, the surface of the primary particles is added. The existing carboxylate ion, sulfate ion, sulfonate ion, phosphate ion, phosphonate ion, amino ion and metal ion (alkali metal ion and / or alkaline earth metal ion and / or transition metal ion) are combined. Then, carboxylate, sulfate, sulfonate, phosphate, phosphonate, and amino acid salt are formed on the surface of the primary particles. Carboxylic acid salts, sulfates, sulfonates, phosphates, phosphonates, and amino acid salts of such metals (alkali metals and / or alkaline earth metals and / or transition metals) function as the anti-fusing agent. . Therefore, primary particles with metal (alkali metal and / or alkaline earth metal and / or transition metal) carboxylate, sulfate, sulfonate, phosphate, phosphonate, amino acid salt formed on the surface are These are so-called “mixed particles”. In addition, since the carboxylate, sulfate, sulfonate, phosphate, phosphonate, and amino acid salt of such metal (alkali metal and / or alkaline earth metal and / or transition metal) are precipitated, the precipitate After being recovered, it may be dried and subjected to a sintering step described later. The drying is performed under reduced pressure conditions (for example, preferably 1 × 10 ⁵ Pa or more and 1 × 10 ⁻⁵ Pa or less, more preferably 1 × 10 ³ Pa or more and 1 × 10 ⁻³ Pa or less, and more preferably 1 × 10 ² Pa or more and 1 × 10 ⁻² Pa or less is most preferable) and heating (0 ° C. or more and 200 ° C. or less is preferable, 20 ° C. or more and 150 ° C. or less is more preferable, and 40 ° C. or more and 120 ° C. or less is most preferable). It is done. The drying is preferably performed under reduced pressure because the drying temperature can be lowered, but may be performed under atmospheric pressure.

  The alkali metal salt is not particularly limited. For example, sodium chloride, sodium hypochlorite, sodium chlorite, sodium bromide, sodium iodide, sodium iodide, sodium oxide, sodium peroxide, Sodium sulfate, sodium thiosulfate, sodium selenate, sodium nitrite, sodium nitrate, sodium phosphide, sodium carbonate, sodium hydroxide, potassium chloride, potassium hypochlorite, potassium chlorite, potassium bromide, potassium iodide Potassium iodide, potassium oxide, potassium peroxide, potassium sulfate, potassium thiosulfate, potassium selenate, potassium nitrite, potassium nitrate, potassium phosphide, potassium carbonate, potassium hydroxide and the like can be used.

  Examples of the alkaline earth metal salt include magnesium chloride, magnesium hypochlorite, magnesium chlorite, magnesium bromide, magnesium iodide, magnesium iodide, magnesium oxide, magnesium peroxide, magnesium sulfate, and magnesium thiosulfate. , Magnesium selenate, magnesium nitrite, magnesium nitrate, magnesium phosphide, magnesium carbonate, magnesium hydroxide, calcium chloride, calcium hypochlorite, calcium chlorite, calcium bromide, calcium iodide, calcium iodate, oxidation Calcium, calcium peroxide, calcium sulfate, calcium thiosulfate, calcium selenate, calcium nitrite, calcium nitrate, calcium phosphide, calcium carbonate, calcium hydroxide and the like can be used.

  Examples of the transition metal salt include zinc chloride, zinc hypochlorite, zinc chlorite, zinc bromide, zinc iodide, zinc iodide, zinc oxide, zinc peroxide, zinc sulfate, zinc thiosulfate, and selenium. Zinc oxide, zinc nitrite, zinc nitrate, zinc phosphide, zinc carbonate, zinc hydroxide, iron chloride, iron hypochlorite, iron chlorite, iron bromide, iron iodide, iron iodide, iron oxide, Iron peroxide, iron sulfate, iron thiosulfate, iron selenate, iron nitrite, iron nitrate, iron phosphide, iron carbonate, iron hydroxide and the like can be used. Moreover, a nickel compound may be sufficient.

  Note that the metal salt (alkali metal salt, alkaline earth metal salt, transition metal salt) added to the solution in which the solution containing the polymer compound and the primary particles are mixed may be one kind or a mixture of two or more kinds. There may be. In addition, the metal salt (alkali metal salt, alkaline earth metal salt, transition metal) may be in a solid state, but for the reason that it can be added uniformly and the concentration to be added can be controlled. It is preferable to add it as an aqueous solution. In addition, the amount (concentration) of the metal salt (alkali metal salt and / or alkaline earth metal salt and / or transition metal salt) to be added depends on the carboxylate ion, sulfate ion, sulfonate ion, phosphoric acid present on the primary particle surface. Combined with ions, phosphonate ions, amino ions, metal (alkali metal and / or alkaline earth metal and / or transition metal) carboxylate, sulfate, sulfonate, phosphate, phosphonate, The conditions are not particularly limited as long as the amino acid salt is generated, and may be determined after appropriate examination.

  Since sodium polyacrylate is soluble in water, it can be used as an anti-fusing agent in this mixing step. However, since calcium polyacrylate is insoluble in water, only polyacrylic acid is temporarily removed from the primary particle surface. It is preferable that calcium acrylate is precipitated on the primary particle surface by adding a calcium salt or the like after adsorbing to the primary particle surface. In addition, since the polymer compound decomposes when the primary particles are calcined at a high temperature (about 300 ° C. or higher), the metal salt of the polymer compound is added to the primary particles so that it functions as an anti-fusing agent even after calcining. It can be said that it is preferable to deposit on the surface. However, when the primary particles are calcined (heat treatment) at a temperature at which the polymer compound is not decomposed (not softened), it is not particularly necessary to deposit the metal salt of the polymer compound on the surface of the primary particles.

(Sintering process)
The sintering step is a step in which the mixed particles obtained in the mixing step are exposed to a sintering temperature, and primary particles contained in the mixed particles are made into ceramic particles (sintered particles). Since the anti-fusing agent is interposed between the primary particles, it is possible to prevent the primary particles from fusing even when exposed to high temperature conditions in the sintering process.

  What is necessary is just to set suitably the sintering temperature in the said sintering process so that the hardness of a ceramic particle may become desired hardness, for example, the inside of the range of 100 to 1800 degreeC is more preferable, and 150 to 1500 degreeC is further more preferable. 200 ° C. to 1200 ° C. is most preferable. The sintering time may be appropriately set based on the desired ceramic particle hardness and the like. In the examples described later, sintering is performed at 800 ° C. for 1 hour.

  In addition, the apparatus etc. which are used for the said sintering process are not specifically limited, What is necessary is just to employ | adopt after selecting a commercially available baking furnace suitably according to a manufacturing scale, manufacturing conditions, etc.

(Removal process)
The said removal process is a process of removing the anti-fusing agent mixed between the particles of the ceramic particle group obtained by the sintering process.

  The removal means and method may be appropriately employed according to the anti-fusing agent employed in the mixing step. For example, when an anti-fusing agent having solvent solubility is used, it is possible to prevent fusion by using a solvent that does not dissolve ceramic particles (non-soluble) and a solvent that dissolves anti-fusing agent (soluble). Only the agent can be dissolved and removed. The solvent to be used is not particularly limited as long as it satisfies the above requirements, and may be an aqueous solvent or an organic solvent. For example, water, ethanol, methanol, etc. are mentioned as an aqueous solvent, and acetone, toluene, etc. are mentioned as an organic solvent.

  The aqueous solvent may contain a chelate compound such as oxalate, ethylenediamine, bipyridine, and ethylenediaminetetraacetate in order to increase the solubility of the anti-fusing agent in water. Further, the aqueous solvent may contain electrolyte ions such as sodium chloride, ammonium nitrate and potassium carbonate in order to increase the solubility of the anti-fusing agent in water.

  However, for the reasons such as that the equipment corresponding to the use of the organic solvent in the removal step becomes unnecessary, the organic solvent waste liquid treatment becomes unnecessary, the safety of the manufacturing work is high, and the risk to the environment is low. The solvent used is preferably an aqueous solvent.

  In the case of hydroxyapatite (HAp) sintered particles, since the hydroxyapatite (HAp) sintered particles dissolve under the condition of pH 4.0 or lower, the removal step can be performed at pH 4.0 to pH 12.0. preferable.

  By the way, when removing the anti-fusing agent using a solvent, after suspending the ceramic particle group containing the anti-fusing agent obtained by the sintering process in the solvent, only the ceramic particles are removed by filtration or centrifugation. Collect it. In the method for producing a ceramic particle group according to this embodiment, the above operation is not limited to once, and may be performed twice or more. It can be said that the removal rate of the anti-fusing agent between the ceramic particles is further improved by performing the above operation a plurality of times. However, it is not preferable to perform the above operation more than necessary because the manufacturing process becomes complicated, the manufacturing cost increases, the recovery rate of ceramic particles decreases, and the like. Therefore, the number of operations may be appropriately determined based on the target anti-fusing agent removal rate.

  This step may further include a step of classifying to make the particle diameter uniform.

  In addition to the method of removing the anti-fusing agent using the solvent, the anti-fusing agent can be removed using a magnet by using a magnetic substance as the anti-fusing agent. More specifically, after suspending and dispersing the ceramic particles (coarse ceramic particles) group containing the anti-fusing agent obtained by the sintering process in an appropriate solvent (water, etc.), the magnetic force is applied to the suspension. , Only the anti-fusing agent is adsorbed to the magnet, and only the ceramic particles that have not been adsorbed are recovered. In addition, a method of separating the anti-fusing agent with a magnet may be performed after the coarse ceramic particles are ground into a powder without being suspended in a solvent. However, it can be said that the removal rate of the anti-fusing agent is higher because the ceramic particles and the anti-fusing agent are more easily separated from the suspension. In addition, it is preferable that the ceramic particle which can apply this method is a nonmagnetic material or a weak magnetic material.

(Pickling process)
The pickling step is a step of washing the ceramic particles (sintered particles) obtained by the sintering step with an acid. The purpose of the cleaning process is to remove calcium carbonate and the like contained in the sintered particles.

  As the acid, a weak acid that does not damage the ceramic particles is used. Examples thereof include hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, nitric acid, or ammonium salts thereof.

  The pickling process is performed by suspending the calcium phosphate sintered body in an acid solution. For example, an operation of suspending a calcium phosphate sintered body in an acid solution, centrifuging, and then discarding the supernatant is performed by adjusting the pH of the supernatant to 6.0 to 9 (preferably 6.5 to 8.5, The pickling step is preferably carried out by repeating until 7.0 to 7.5). More specifically, for example, HAp is suspended in a 0.2 wt% ammonium nitrate aqueous solution, subjected to ultrasonic irradiation for 5 minutes, subjected to solid-liquid separation by centrifugation, and the supernatant is discarded. After repeating this operation until the pH of the supernatant is 8, the pickling step may be performed by suspending in deionized water, centrifuging, and discarding the supernatant three times or more. .

(Crushing process)
The pulverization step is a step of pulverizing the aggregate after the sintering step to obtain a calcined calcium phosphate particle group having a desired size. Here, normally, the fired body that has been made into secondary particles can hardly be reduced to the size of the primary particles even if a considerable pulverization step is performed. On the other hand, according to the method of the present embodiment, it is possible to easily pulverize to the primary particle size level even with a simple pulverization process. Here, the pulverization method is not particularly limited, and examples thereof include ultrasonic treatment and pulverization using a pulverized sphere. After the pulverization treatment, particles having a smaller diameter may be collected by removing unpulverized ones.

(Drying process)
A drying process is a process of removing a solvent by heating etc. after the said grinding | pulverization process or the said washing | cleaning process, and obtaining a calcium-phosphate particle group. The drying method is not particularly limited.

<< 2. Calcium phosphate sintered particles obtained by the second production method >>
<2-1. Spherical Calcium Phosphate Sintered Particle Group>
The spherical calcium phosphate sintered body particle group obtained by this production method is a ceramic particle group including ceramic particles, and the ceramic particles have a particle diameter in the range of 10 nm to 700 nm, and the ceramic particles are sintered with calcium phosphate. A group of ceramic particles, wherein the ceramic particles are substantially free of calcium carbonate. Furthermore, the ceramic particles include carbonate apatite at least on the surface thereof.

  Furthermore, the spherical calcium phosphate sintered body particle group obtained by this production method preferably has a coefficient of variation of the particle diameter of the ceramic particle group of 30% or less, preferably 25% or less, It is particularly preferable that it is 20% or less. The ceramic particle group is a fine particle and a uniform particle size (narrow particle size distribution). Therefore, there is an effect that it can be more uniformly adsorbed to the medical polymer material without performing an additional operation such as a particularly advanced classification. And since it does not contain calcium carbonate, when using as a biomaterial, it becomes possible to prevent the situation from which the biocompatibility and solubility of a material change. The ceramic particle group exhibits high dispersibility.

  Further, from another aspect, the spherical calcium phosphate sintered body particle group obtained by the present production method is a ceramic particle group including spherical ceramic particles, and is composed of primary particles composed of a single crystal, or primary particles composed of the single crystal. When a particle lump in which particles are aggregated by ionic interaction is a single crystal primary particle, the ratio of the single crystal primary particles contained in the ceramic particle group occupies a majority, and the ceramic particles are sintered calcium phosphate particles. The ceramic particle group is characterized by being substantially free of calcium carbonate. The ceramic particle group is a primary particle composed of a single crystal having a superior dispersibility in a solvent, or a particle lump in which the primary particles composed of the single crystal are assembled by ionic interaction (single crystal primary particles). Exist as. Therefore, there is an effect that the adsorption to the medical polymer base material described above is facilitated. Moreover, since there is no coupling | bonding of primary particles, a specific surface area is high. Furthermore, since it is highly stable in vivo and excellent in dispersibility, it has an effect that it can be used as a medical material capable of carrying and sustained release of a drug. And since it does not contain calcium carbonate substantially, when it uses as a biomaterial, the biocompatibility of material and the original solubility of calcium phosphate are maintained. In addition, it is good also considering the particle lump which the primary particle which consists of the said single crystal assembled by the ionic interaction in this way as a ceramic particle.

  Further, in the ceramic particle group, the ratio of the single crystal primary particles contained in the ceramic particle group may be 70% or more. By taking such a structure, there exists an effect that it becomes easy to adsorb | suck to a medical polymeric base material.

  Moreover, the ceramic particle group may have a particle diameter of the ceramic particles in a range of 10 nm to 700 nm. According to the said structure, there exists an effect that it can adsorb | suck more uniformly with respect to medical polymeric material.

  The ceramic particle group may have a coefficient of variation of the particle diameter of the ceramic particle group of 20% or less. By adopting such a configuration, there is an effect that it can be more uniformly adsorbed to the medical polymer material without performing an additional operation such as particularly high classification.

  The ceramic particles may be hydroxyapatite (HAp) sintered particles. The particles are composed of a hydroxyapatite (HAp) sintered body that has higher biocompatibility and can be used for a wide range of applications. Therefore, it is particularly preferable as a medical material.

<2-2. Rod-like Calcium Phosphate Sintered Particle Group>
The rod-shaped calcium phosphate sintered body particle group obtained by this production method is a ceramic particle group containing ceramic particles, and the particle diameter of the ceramic particles is such that the maximum diameter of the short axis is 30 nm to 5 μm, and the long axis is 75 nm to 10 μm, growing in the c-axis direction, and having a crystal aspect ratio (c-axis length / a-axis length) of 1 to 30, wherein the ceramic particles are calcium phosphate sintered particles, The ceramic particle group is substantially free of calcium carbonate. Furthermore, the ceramic particles include carbonate apatite at least on the surface thereof.

  Since the rod-shaped calcium phosphate baked particles have a much larger area for adhesion than conventional fine particles, the adhesion to the polymer base material can be improved, so that the surface of the polymer such as biocompatible medical materials such as catheters can be improved. Suitable for modification. And since it does not contain calcium carbonate substantially, when using as a biomaterial, it becomes possible to prevent the situation where carbon dioxide gas is generated from a material. In addition, as a method for modifying the polymer surface, graft polymerization may be carried out by grafting an active group of calcium phosphate (for example, hydroxyapatite (HAp) nanoparticles) and a polymer substrate, for example, a vinyl polymerizable monomer having a carboxyl group on the surface. It is possible to use a method of chemically reacting with an active group of silicone rubber, a method of using a curable adhesive, a method of using a curable adhesive, a method of heating a polymer substrate to the vicinity of the melting point, and embedding it in the substrate. (This also applies to the spherical calcium phosphate sintered body particles described above). The rod shape may be a truncated columnar structure with a tip angle having an oblique surface.

  The ceramic particles may be hydroxyapatite sintered particles. The particles are composed of a hydroxyapatite sintered body that has higher biocompatibility and can be used for a wide range of applications. Therefore, it is particularly preferable as a medical material.

<2-3. Calcium phosphate sintered particles represented by general formula>
The calcium phosphate sintered particles of the above-mentioned 2-1 and 2-2 obtained by the present production method have the following general formula Ca _x (PO ₄ ) _6-y (CO ₃ ) _y (OH) ₂
(Wherein x is a number of 8 or more and 12 or less (preferably a number of 9 or more and 11 or less, more preferably a number of 9.5 or more and 10.5 or less), and y is greater than 0 and 3 or less. A number (preferably a number greater than 0 and less than or equal to 2, more preferably a number greater than 0 and less than or equal to 1)
It may be represented by

The measuring method of Ca, (PO ₄ ) and CO ₃ is as follows. For Ca and PO ₄ , the measurement solution is dissolved in 1N nitric acid, the measurement solution is adjusted to 100 ppm in terms of formula weight, and the above measurement solution is measured using ICP emission analysis (manufactured by Thermo Fisher Scientific, iCAP7600Duo). Measure. In addition, CO ₃ was measured at 10 ° C./min. Under a nitrogen stream using a thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR6000). The amount of decarboxylation is evaluated from the weight decreased in the temperature range of 700 ° C to 950 ° C.

<2-3. Structure>
Next, the structure of the calcium phosphate sintered body particle group obtained by the manufacturing method according to this embodiment will be described.

  This embodiment is a calcium phosphate sintered body particle group mainly characterized by not containing calcium carbonate. Moreover, at least the surface contains carbonate apatite.

  The inventors have found that when the invention of Patent Document 1 is implemented, calcium carbonate is generated on the surface of the calcium phosphate sintered particles. Surprisingly, the calcium phosphate sintered body is not only used when using an anti-fusing agent containing carbonic acid such as calcium carbonate, but also when using an anti-fusing agent containing no carbonic acid such as calcium nitrate and sodium nitrate. Calcium carbonate was generated on the surface of the particles (see Comparative Examples 2-2 and 2-3 below). The reason is that calcium nitrate and sodium nitrate change to calcium oxide and sodium oxide when heated. These substances are strong bases and react with carbon dioxide present in the electric furnace to produce calcium carbonate. In addition, since hydroxyapatite (HAp) easily causes ion exchange, ions constituting the salt used as the anti-fusing agent and ions constituting hydroxyapatite (HAp) are exchanged to change the crystal structure. In that case, it is estimated that the hydroxyapatite surface becomes excessive in calcium ions and reacts with carbon dioxide in the electric furnace to generate calcium carbonate. The inventors of the present invention have found that carbonate apatite is generated on the surface of the calcium phosphate sintered body particles (particle group) by removing the calcium carbonate by a pickling process or the like.

  In this embodiment, calcium carbonate is not included, and at least the surface of the calcium phosphate sintered body particles (particle group) contains carbonate apatite, thereby suppressing biocompatibility reduction and solubility change, and high dispersibility. It becomes possible to make the calcium phosphate sintered body particles shown.

  Furthermore, in this embodiment, by not containing an alkali metal element, it becomes possible to obtain calcium phosphate sintered body particles that have higher crystallinity, are difficult to dissolve, and are excellent in cell adhesion.

Here, “does not contain calcium carbonate” means that calcium carbonate is not substantially contained, and does not necessarily exclude trace amounts, but more specifically, the following (1) to ( Satisfy the criteria of 3).
(1) From the measurement result of X-ray diffraction, calcium carbonate is calcium carbonate (formula weight: 100.09) / hydroxyapatite (formula weight: 1004.62) = 0.1 / 99.9 (formula weight conversion ratio) or less. It is.
(2) In thermogravimetric differential thermal analysis (TG-DTA) measurement, a weight loss of 2% or more with a clear endotherm is not observed at 650 ° C to 800 ° C.
(3) In the FT-IR spectra obtained in the measurement Kubelka-Munk (KM) chart showing the calculated absorbance by the equation, separated peaks wavenumber appears between ^{860cm -1 ~890cm} -1, is attributed to calcium carbonate A peak around 877 cm ⁻¹ is not observed. The peak separation is performed by using, for example, software called fityk 0.9.4 under the conditions of Function Type: Gaussian and Fitting Method: Levenberg-Marquardt.

“Containing carbonate apatite” means that carbonate apatite is present as a result of measurement according to a known method for measuring carbonate apatite. For example, the FT-IR ^spectrum, means that the absorption is observed 1350cm ^-1 ~1500cm -1.

The FT-IR analyzer and measurement conditions are as follows. A hydroxyapatite (HAp) calcined particle group was taken so as to be 10% by weight with respect to potassium bromide [KBr], and a measurement sample sufficiently ground in an agate mortar was diffusely reflected using FT-IR Spectrum 100 manufactured by PerkinElmer. by measuring the range of ^{450cm -1 ~4000cm} -1 at 8 cumulative.

  The thermogravimetric differential thermal analysis (TG-DTA) measurement conditions are as follows. Thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR 6000) under a nitrogen stream at 10 ° C./min. The amount of decarboxylation is evaluated from the weight decreased in the temperature range of 700 ° C to 950 ° C.

  Further, “not containing an alkali metal element” means that, with respect to each alkali metal element, the weight of the alkali metal element is 10 ppm or less (preferably 1 ppm or less) with respect to the total weight of the calcium phosphate sintered body particles. In addition, a conventionally well-known method can be applied as an analysis method, for example, it may analyze by ICP-MS.

  Furthermore, as described above, according to this embodiment, it is possible to obtain a calcium phosphate sintered body particle group that does not contain an alkaline earth metal element other than calcium or a transition metal element.

  Thus, by containing substantially no alkaline earth metal elements other than calcium and transition metal elements, the crystallinity is further enhanced, the dissolution is difficult, and the calcium phosphate sintered body particles are excellent in cell adhesion. It becomes possible to do. Moreover, it becomes possible to improve the safety | security to a biological body substantially by not containing a transition metal element.

  In addition, “not containing an alkaline earth metal element other than calcium” (“not containing a transition metal element”) means a calcium phosphate sintered body for each alkaline earth metal element (each transition metal element) as described above. It indicates that the weight of the alkaline earth metal element (transition metal element) other than calcium is 10 ppm or less (preferably 1 ppm or less) with respect to the weight of the entire particle. In addition, a conventionally well-known method can be applied as an analysis method, for example, it may analyze by ICP-MS.

  Here, when it is desired to manufacture a calcium phosphate sintered body particle group that does not contain an alkali metal element, does not contain an alkaline earth metal element other than calcium, and / or does not contain a transition metal element, As a selection of the anti-fusing agent), it is conceivable to use one not containing the element.

Here, the calcium phosphate particle group obtained by this production method further has the following property (A) as moisture adsorptivity.
(A) After sufficiently drying (for example, after drying for 18 hours or more under normal pressure, temperature 60 ° C., humidity 45-85%), under normal pressure, temperature 25 ° C., humidity 50% After being allowed to stand for 3 days or longer, a thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR6000) under a nitrogen stream at 10 ° C./min. The weight decreased in the temperature range of 25 to 200 ° C. is 2% or less.

  It has been found that the cell adhesion can be further improved by the calcium phosphate particle group satisfying such properties.

  Moreover, it is suitable for the calcination calcium phosphate particle group in this form that the half value width in d = 2.814 measured by X ray diffraction method (XRD) satisfy | fills 0.2-0.8, 0 It is more preferable to satisfy 3 to 0.7. By setting the half width of the calcined calcium phosphate particle group within this range, the solubility can be further reduced and the cell adhesion can be further improved.

  In the adjustment of the half width, the firing temperature and the firing time may be adjusted as appropriate. When the half width is desired, for example, the firing temperature (maximum temperature reached) is set to 600 to 800 ° C. The holding time may be set to 0 to 1 h or the like.

  Here, the calcium phosphate obtained by this production method further contains B-type carbonate apatite. It has been found that the cell adhesiveness can be further improved by the calcium phosphate satisfying such properties.

In addition, in the analysis by the above-mentioned FT-IR spectrum, when two absorption peaks are observed at 1350 cm ^{−1 to} 1500 cm ⁻¹ , it is considered “contains carbonate apatite” and “contains B-type carbonate apatite”. {For example, in FIG. 2-4 and the like to be described later, of the two absorption peaks seen in the range of 1350 cm ^{−1 to} 1500 cm ⁻¹ , the right peak (1350 cm ⁻¹ side) is the absorption peak of B-type carbonate apatite Is considered to be equivalent}.

<A-2. Base material>
As a base material used for the medical implant which concerns on this invention, the material of a well-known medical implant can be mentioned, For example, inorganic material (For example, metallic materials, for example, titanium, chromium, cobalt, these. Alloys; ceramic materials such as alumina, titania, zirconia, calcium phosphate) and polymeric materials such as PEEK and polylactic acid.

≪Method for manufacturing ceramic-supported medical implant≫
Next, examples of techniques for bonding ceramic particles to medical implants (that is, methods for producing an implant having ceramic particles attached thereto) include known techniques such as WO 2010/125686, WO 2010-058848, and the like. it can.

<<<< first embodiment >>
<< Production Example >>
(Example 1-1: Spherical hydroxyapatite fired body particle group)
In a reaction vessel containing deionized water, calcium nitrate tetrahydrate, diammonium hydrogen phosphate aqueous solution and aqueous ammonia were added with stirring {calcium: phosphoric acid (molar ratio) = 5: 3}, and hydroxy Apatite primary particles were obtained. Thereafter, the operation of transferring the supernatant in the reaction vessel to a waste water vessel, adding deionized water, stirring with a stirrer, and transferring the supernatant to a waste vessel was repeated twice. Thereafter, the reaction vessel containing the precipitate was frozen overnight at −10 ° C. to −25 ° C. Thereafter, the mixture was thawed at room temperature and the thawed precipitate was collected by filtration. Thereafter, about 400 g of precipitate was put in a baking dish, put in a baking furnace, heated to 600 ° C. over 1 hour, kept at 600 ° C. for 1 hour, and then cooled for 1 hour or more to carry out baking. Then, deionized water was added to the fired body and irradiated with ultrasonic waves for 30 minutes or more. Then, the mixture was transferred to a pod mill, and pulverized balls were added and pulverized for 1 hour. After the pulverization was completed, the powder was transferred to a hand-held beaker, and an unground baked product was removed using a 150 μm sieve. After that, deionized water washing was repeated 6 times. Then, it dried at 60-80 degreeC, and obtained the hydroxyapatite baking body which concerns on Example 1-1 which does not contain an alkali metal element.

(Example 1-2: Rod-like hydroxyapatite fired body particle group)
In a reaction vessel containing deionized water, while stirring the calcium nitrate tetrahydrate aqueous solution, diammonium hydrogen phosphate aqueous solution and aqueous ammonia were dropped into the calcium nitrate tetrahydrate aqueous solution {calcium: phosphoric acid (mol). Ratio) = 5: 3} to obtain primary particles of hydroxyapatite. Thereafter, the operation of transferring the supernatant in the reaction vessel to a waste water vessel, adding deionized water, stirring with a stirrer, and transferring the supernatant to a waste vessel was repeated 5 times. Thereafter, the reaction vessel containing the precipitate was frozen overnight at −10 ° C. to −25 ° C. Thereafter, the mixture was thawed at room temperature and the thawed precipitate was collected by filtration. Thereafter, about 400 g of precipitate was put in a baking dish, put in a baking furnace, heated to 600 ° C. over 1 hour, kept at 600 ° C. for 1 hour, and then cooled for 1 hour or more to carry out baking. Then, deionized water was added to the fired body and irradiated with ultrasonic waves for 30 minutes or more. And it moved to the pod mill, put the pulverization ball | bowl, and grind | pulverized for 1 hour. After the pulverization was completed, the powder was transferred to a hand-held beaker, and an unground baked product was removed using a 150 μm sieve. Thereafter, deionized water washing was repeated 7 times. Then, it dried at 60-80 degreeC, and obtained the hydroxyapatite baking body which concerns on Example 1-2 which does not contain an alkali metal element. The ceramic particles have a minor axis average maximum diameter of 47 nm and a major axis of 157 nm, grow in the c-axis direction, and the crystal aspect ratio (c-axis length / a-axis length) is 3. 3 and was a ceramic particle having a truncated columnar structure with a beveled tip angle.

(Comparative Example 1-1)
According to Example 1 of Japanese Patent No. 5043436, a hydroxyapatite fired body according to Comparative Example 1-1 was obtained.

<< X-ray diffraction test >>
1-1, FIG. 1-2, and FIG. 1-3 are the results of the X-ray diffraction measurement of the calcined hydroxyapatite according to Example 1-1, Example 1-2, and Comparative Example 1-1, respectively. As can be seen from the figure, a peak of calcium carbonate was not observed in FIG. 1-1, whereas a clear peak of calcium carbonate was observed in FIG. 1-3. Moreover, also about Example 1-2, it can confirm that the peak of a calcium carbonate is not observed similarly to Example 1-1. More specifically, in FIG. 1-1, only a pattern corresponding to hydroxyapatite (PDF 74-0565) can be confirmed, while in FIG. 1-3, a peak that does not exist in hydroxyapatite is observed at 29.4 °. It was consistent with calcium carbonate (calcite: PDF 72-1937). The X-ray diffractometer and measurement conditions are as follows. Crystal structure analysis was performed using a powder X-ray diffraction device {MiniFlex} manufactured by Rigaku Corporation. The X-ray source used in XRD was a CuKα source {λ = 1.541841 Å (angstrom)}, output was 30 kV / 15 mA, scan speed was 1.0 ° / min, sampling width was 0.01 °, measurement The mode was a continuous condition.

  In addition, when the half value width in d = 2.814 was measured on the same conditions as the said X-ray-diffraction test, Example 1-1 is about 0.4 and Example 1-2 is about 0.5. there were.

<< Appearance observation test >>
1-4 and FIGS. 1-5 are SEM photographs of the hydroxyapatite fired body particle group according to Example 1-1 (scale difference). From these photographs, the hydroxyapatite fired body particle group according to Example 1-1 is a hydroxyapatite fired body particle group including spherical hydroxyapatite fired body particles, which are primary particles composed of a single crystal, or from the single crystal. Assuming that a particle lump in which the primary particles are aggregated by ionic interaction is a single crystal primary particle, it can be seen that a majority of the single crystal primary particles contained in the hydroxyapatite fired body particle group occupy the majority. FIGS. 1-6 and 1-7 are SEM photographs of the hydroxyapatite fired body particle group according to Example 1-2 (difference in scale).

<< Particle size measurement test >>
Regarding the hydroxyapatite fired bodies (endotoxin non-inactivated) according to Example 1-1 and Comparative Example 1-1, the average particle diameter and standard deviation were calculated (9 images were acquired by SEM, and 1 image was obtained) The particle size of 12 particles was measured, the particle size of a total of 108 particles was confirmed, and the average value and standard deviation were calculated). In addition, the average particle size and standard deviation were similarly calculated (9 points by SEM) for the inactivated hydroxyapatite fired bodies (endotoxin non-inactivated) according to Example 1-1 and Comparative Example 1-1. And the particle size of 12 particles in one point of the image was measured, and the particle size of a total of 108 particles was confirmed, and an average value and a standard deviation were calculated. The inactivation procedure is as follows: (1) dry heat sterilization (300 ° C., 2 hours), measure HAp powder into ampoule; (2) leave the ampoule with HAp open in a dry heat sterilizer. Dry heat sterilization (300 ° C., 2 hours), (3) sealing the ampule cooled to room temperature (sealed tube), and (4) sterilizing the sealed ampule again with a dry heat sterilizer (300 ° C, 2 hours). Table 1-1 is a hydroxyapatite fired body according to Example 1-1, and Table 1-2 is a hydroxyapatite fired body according to Comparative Example 1-1.

<< Thermogravimetric differential thermal analysis >>
Thermogravimetric differential thermal analysis (TG-DTA) measurement was performed on the hydroxyapatite fired particles according to Example 1-1, Example 1-2, and Comparative Example 1-1, and in the examples, the temperature was 650 ° C to 800 ° C. It was confirmed that no weight loss of 2% or more with clear endotherm was observed. On the other hand, in Comparative Example 1-1, a weight loss of 2% or more with a clear endotherm at 650 ° C. to 800 ° C. was observed.

  The thermogravimetric differential thermal analysis (TG-DTA) measurement conditions are as follows. Thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR 6000) under a nitrogen stream at 10 ° C./min. The amount of decarboxylation was evaluated from the weight decreased in the temperature range of 700 ° C to 950 ° C.

  Furthermore, as a moisture adsorption test, the hydroxyapatite calcined particle group according to Example 1-1 was dried for 18 hours or more under the conditions of a temperature of 60 ° C. and a humidity of 45 to 85%, and then the temperature was 25 ° C. under normal pressure. And a humidity of 50% for 3 days or more, and a thermogravimetric differential thermal analyzer (TG-DTA) (EXSTAR 6000, manufactured by Seiko Instruments Inc.) under a nitrogen stream at 10 ° C./min. When the weight decreased in the temperature range of 25 to 200 ° C. was measured, it was 1.43%. Moreover, when a similar test was performed on Example 2-1, a similar level of result was obtained.

<< FT-IR analysis >>
The hydroxyapatite fired body particle group according to Example 1-1, Example 1-2, and Comparative Example 1-1 was subjected to FT-IR analysis. In particular, in chart showing the absorbance of calculating the spectrum obtained in the FT-IR measurement in Kubelka-Munk (KM) equation, to separate the peak wavenumber appears between ^{860cm -1 ~890cm} -1, it was evaluated. As a result, in the hydroxyapatite fired body particle group according to Example 1-1 and Example 1-2, it was confirmed that a peak near 877 cm ⁻¹ attributed to calcium carbonate was not observed. On the other hand, in the hydroxyapatite fired body particle group according to Comparative Example 1-1, a peak near 877 cm ⁻¹ attributed to calcium carbonate was observed.

The FT-IR analyzer and measurement conditions are as follows. A hydroxyapatite (HAp) calcined particle group was taken so as to be 10% by weight with respect to potassium bromide [KBr], and a measurement sample sufficiently ground in an agate mortar was diffusely reflected using FT-IR Spectrum 100 manufactured by PerkinElmer. the range of ^{450cm -1 ~4000cm} -1 at was measured at 8 cumulative. In addition, peak separation was performed by using software called fityk 0.9.4 under the conditions of Function Type: Gaussian and Fitting Method: Levenberg-Marquardt.

From the results of X-ray diffraction test, thermogravimetric differential thermal analysis, and FT-IR analysis, Example 1-1 and Example 1-2 were substantially free of calcium carbonate.
On the other hand, Comparative Example 1-1 and Comparative Example 1-2 contain calcium carbonate from the results of thermogravimetric differential thermal analysis.

<< Foaming confirmation test >>
Furthermore, the hydroxyapatite fired bodies according to Examples 1-1 and 1-2 and Comparative Example 1-1 were shown in Purity test (4) Carbonate listed in Quasi-drug raw material standard 2006 “Hydroxyapatite”. The test was conducted according to the procedure. Specifically, 1.0 g of a sample was weighed at room temperature (20 ° C.), 5 mL of water was added and shaken, and the mixture was deaerated by reducing pressure for 1 hour using an aspirator. After deaeration, 2 mL of concentrated hydrochloric acid (35.0% by mass) was added to check for foaming. As a result, foaming could not be confirmed in the HAp obtained in the example (gas generation amount was less than 0.25 ml). On the other hand, in the HAp obtained by the comparative example, the resulting foam was so foamed that the supernatant became cloudy (gas generation amount was 0.25 ml or more).

<< Cell adhesion test >>
<Manufacture of test materials>
(Cleaning process)
A circular polyethylene terephthalate (PET) sheet (diameter 9 mm, thickness 0.1 mm) was subjected to alcohol treatment (irradiation with ultrasonic waves in alcohol (ethanol, 2-propanol, etc.) for 5 minutes).

(Linker introduction process)
Corona discharge treatment (100 V, 15 seconds on one side) was applied to both surfaces of the PET sheet that had been subjected to the cleaning treatment. A PET sheet after corona discharge treatment and 10 ml of acrylic acid (manufactured by Wako Pure Chemical Industries, Ltd.) were placed in a 20 ml test tube, and the inside of the test tube was depressurized with a vacuum pump to perform a deaeration operation. The test tube was sealed under reduced pressure, and graft polymerization was performed in a water bath at a temperature of 60 ° C. for 60 minutes. After the treatment, in order to remove the acrylic acid homopolymer adhering to the substrate surface, the substrate was stirred in water at room temperature for 60 minutes, and then the substrate surface was washed with water and subsequently with ethanol.

(Sintered hydroxyapatite fine particle immobilization treatment)
After the above treatment, the base material was dispersed in 1% sintered hydroxyapatite fine particles (sintered hydroxyapatite fine particles according to Example 1-1, Example 1-2 or Comparative Example 1-1) (dispersion medium: ethanol). ) And left at 20 ° C. for 30 minutes. Then, ultrasonic irradiation was performed for 5 minutes, the base material was taken out and dried at 20 ° C. and normal pressure to obtain a test material.

<Evaluation of cell adhesion and cell morphology>
Cell adhesion and cell morphology evaluation tests were performed using the prepared test materials. Prior to the test, the test material was washed with ethanol, washed with phosphate buffered saline (PBS) and medium (MEM α (serum-free)) (3 times), then immersed in the medium and incubated until use. (37 ° C., 5% CO ₂ ). And cell culture was implemented in the following procedures. First, a culture medium (200 μL / hole) and a test material (test sheet) were placed in a 48-well plate. Thereafter, a suspension of osteoblast-like cells (MC3T3-E1 (subclone 14)) was added (about 1 × 10 ⁵ cells / 200 μL / well) and cultured for 3 hours.

(Cell observation)
1-8 to 1-10 are SEM photographs of specimens manufactured using the hydroxyapatite sintered particles according to Example 1-1, Example 1-2, and Comparative Example 1-1, respectively. It is. Based on the photograph, the state of cell aggregation, cell morphology, and cell density were determined. The results are shown in Table 1-3. As for the cell density, the greater the number of “+”, the higher the cell density. Moreover, the average coverage of each test material is calculated from SEM photographs.

(Dyeing observation)
Subsequently, staining observation was performed according to the following procedure. First, the test sheet was washed with PBS to remove non-adherent cells, fixed (4% PFA) and surfactant (0.5% Triton X-100 / PBS), and then AlexaFluor ( After adding 488-labeled Acti-stain, it was encapsulated with an encapsulating agent (with nuclear dye DAPI). With a fluorescence microscope (Nikon, ECLIPSE Ti-S), a laser beam of 488 nm was irradiated, and the cell morphology was confirmed by staining of actin fibers. A laser beam of 405 nm was irradiated to confirm staining of cell nuclei. The results are shown in FIGS. 1-11 and 1-12. FIGS. 1-11 and 1-12 are actin-derived fluorescence images and cell nucleus-derived samples prepared using the hydroxyapatite sintered particles according to Example 1-1 and Example 1-2. It is the image which synthesize | combined these fluorescent images. As can be seen from the figure, when the hydroxyapatite sintered particles according to Example 1-1 and Example 1-2 are used, actin fibers are sufficiently developed to exhibit excellent cell adhesion. It was also confirmed that most of the cells showed a greatly expanded cell morphology.

  From the above results, it was confirmed that the calcium phosphate fine particles according to this example had a polygonal cell shape and significantly promoted cell-cell adhesion. From this, it became clear that the calcium phosphate microparticles according to this example promote morphological differentiation of cells.

<< Crystallinity >>
Crystal structure analysis was performed using a powder X-ray diffraction apparatus {MiniFlex 600, manufactured by Rigaku Corporation). The X-ray source used in XRD is a CuKα source {λ = 1.541841 Å (angstrom)}, output is 30 kV / 15 mA, scan speed is 10.0 ° / min, sampling width is 0.02 °, measurement The mode was a continuous condition. The average crystallite size τ (nm) is given by the following Scherrer equation.
(Scherrer's formula) τ = Kλ / βcosθ
K is a shape factor of 0.9. λ is the X-ray wavelength, β is the half width of the top peak, and θ is the Bragg angle of the top peak. The average crystallite size τ (nm) was calculated from the measured value of X-ray diffraction using the above equation.

  The average size τ of the crystallites of the calcium phosphate fine particles according to Example 1-1 was 11.6 nm, and the average size τ of the crystallites of the calcium phosphate fine particles according to Comparative Example 1-1 was 12.1 nm. Therefore, it is understood that the calcium phosphate fine particles according to this example have higher crystallinity.

<<< second embodiment >>>
<< Production Example >>
(Example 2-1: Spherical hydroxyapatite (HAp) sintered body particle group including carbonate apatite)
(Primary particle generation process)
In a reaction vessel containing deionized water, calcium nitrate tetrahydrate, aqueous diammonium hydrogen phosphate solution and aqueous ammonia were added with stirring {calcium: phosphoric acid (molar ratio) = 5: 3}, 24 The reaction was allowed to stir at room temperature for an hour. Hydroxyapatite (HAp) primary particles were obtained.
(Mixing process)
By dispersing 1.0 g of hydroxyapatite (HAp) primary particle group in 100 ml of an aqueous solution having a pH of 12.0 containing 1.0 g of sodium polyacrylate (manufactured by ALDRICH, weight average molecular weight: 15,000 g / mol), Sodium polyacrylate was adsorbed on the surface of the particles. The pH of this aqueous solution was measured using a CyberScan pH 1100 manufactured by EUTECH and a CyberScan pH 1100 manufactured by EUTECH.
Next, 100 ml of a 0.12 mol / l calcium nitrate [Ca (NO ₃ ) ₂ ] aqueous solution was added to the dispersion prepared above to precipitate calcium polyacrylate on the surface of the primary particles. Such calcium polyacrylate is an anti-fusing agent. The resulting precipitate was collected and dried at 80 ° C. under reduced pressure (about 0.1 Pa) to obtain mixed particles.
(Sintering process)
The mixed particles were put in a crucible, heated to a sintering temperature of 600 ° C. at a heating rate of 200 ° C./hour, and held for 1 hour for sintering. At this time, the calcium polyacrylate was thermally decomposed to become calcium oxide [CaO], and a part thereof became calcium carbonate [CaCO ₃ ].
(Pickling process)
In order to increase the solubility of the anti-fusing agent and calcium carbonate in water, an aqueous solution of 50 mmol / l ammonium nitrate [NH ₄ NO ₃ ] was prepared. Next, the sintered body obtained in the above step is suspended in 500 ml of the aqueous solution prepared above, subjected to ultrasonic irradiation for 5 minutes and subjected to solid-liquid separation by centrifugation, and the resulting precipitate is again made into an ammonium nitrate aqueous solution. The suspension was subjected to ultrasonic irradiation, centrifugation, and the above steps were repeated until the supernatant had a pH of 7.5 or less. The suspension was further suspended in distilled water, and similarly separated and washed by centrifugation to remove the anti-fusing agent and ammonium nitrate, and to recover highly crystalline hydroxyapatite (HAp) fine particles.

(Example 2-2: Rod-like hydroxyapatite (HAp) fired body particle group including carbonate apatite)
(Primary particle generation process)
In a reaction vessel containing deionized water, calcium nitrate tetrahydrate, aqueous diammonium hydrogen phosphate solution and aqueous ammonia were added with stirring {calcium: phosphoric acid (molar ratio) = 5: 3}, 24 The reaction was allowed to proceed with stirring at 80 ° C. for an hour. Hydroxyapatite (HAp) primary particles were obtained.
(Mixing process) ・ (Sintering process) ・ (Pickling process)
It carried out similarly to Example 2-1.

(Comparative Example 2-1: Hydroxyapatite-fired (HAp) adult particle group manufactured based on Japanese Patent No. 5044336 using a fusion prevention agent as calcium polyacrylate)
(Primary particle generation process)
In a reaction vessel containing deionized water, calcium nitrate tetrahydrate, aqueous diammonium hydrogen phosphate solution and aqueous ammonia were added with stirring {calcium: phosphoric acid (molar ratio) = 5: 3}, 24 The reaction was allowed to stir at room temperature for an hour. Hydroxyapatite (HAp) primary particles were obtained.
(Mixing process)
By dispersing 1.0 g of hydroxyapatite (HAp) primary particle group in 100 ml of an aqueous solution having a pH of 12.0 containing 1.0 g of sodium polyacrylate (manufactured by ALDRICH, weight average molecular weight: 15,000 g / mol), Sodium polyacrylate was adsorbed on the surface of the particles. The pH of this aqueous solution was measured using a CyberScan pH 1100 manufactured by EUTECH and a CyberScan pH 1100 manufactured by EUTECH.
Next, 100 ml of a 0.12 mol / l calcium nitrate [Ca (NO ₃ ) ₂ ] aqueous solution was added to the dispersion prepared above to precipitate calcium polyacrylate on the surface of the primary particles. Such calcium polyacrylate is an anti-fusing agent. The resulting precipitate was collected and dried at 80 ° C. under reduced pressure (about 0.1 Pa) to obtain mixed particles.
(Sintering process)
The mixed particles were put in a crucible, heated to a sintering temperature of 600 ° C. at a heating rate of 200 ° C./hour, and sintered for 1 hour. At this time, the calcium polyacrylate was thermally decomposed to become calcium oxide [CaO], and a part thereof became calcium carbonate [CaCO ₃ ].
(Removal process)
In order to increase the solubility of the anti-fusing agent in water, a 50 mmol / l ammonium nitrate [NH ₄ NO ₃ ] aqueous solution was prepared. Next, the sintered body obtained in the above step is suspended in 500 ml of the aqueous solution prepared above, separated and washed by centrifugation, suspended in distilled water, and similarly separated and washed by centrifugation. The anti-fusing agent and ammonium nitrate were removed, and highly crystalline hydroxyapatite (HAp) fine particles were recovered.

(Comparative Example 2-2: Hydroxyapatite fired body particle group produced based on Japanese Patent No. 5044336 using a fusion inhibitor as calcium nitrate)
(Primary particle generation process)
Similar to Comparative Example 2-1.
(Mixing process)
1.0 g of hydroxyapatite (HAp) primary particles were suspended in 100 ml of a 0.12 mol / l calcium nitrate aqueous solution. The resulting precipitate was collected and dried at 80 ° C. under reduced pressure (about 0.1 Pa) to obtain mixed particles.
(Sintering process) ・ (Removal process)
Similar to Comparative Example 2-1.

(Comparative Example 2-3: hydroxyapatite fired particles group produced based on Japanese Patent No. 5043436 using the fusion inhibitor as sodium nitrate)
(Primary particle generation process)
Similar to Comparative Example 2-1.
(Mixing process)
1.0 g of hydroxyapatite (HAp) primary particle group was suspended in 100 ml of 0.12 mol / l sodium nitrate aqueous solution. The resulting precipitate was collected and dried at 80 ° C. under reduced pressure (about 0.1 Pa) to obtain mixed particles.
(Sintering process) ・ (Removal process)
Similar to Comparative Example 2-1.

  In Examples 2-1 to 2-2, the weight of the alkali metal element or the like was 10 ppm or less.

<< X-ray diffraction test >>
X-ray diffraction measurement was performed on the hydroxyapatite fired bodies according to Example 2-1, Example 2-2, and Comparative Examples 2-1 to 2-3. As a result, the calcium carbonate peak was not observed in the calcined hydroxyapatite according to the example, whereas the calcium carbonate peak was observed in the calcined hydroxyapatite according to the comparative example. More specifically, in the hydroxyapatite fired body according to the example, only a pattern corresponding to the hydroxyapatite (PDF 74-0565) can be confirmed, while in the hydroxyapatite fired body according to the comparative example, it does not exist in the hydroxyapatite. A peak was observed at 29.4 ° and coincided with calcium carbonate (calcite: PDF 72-1937). The X-ray diffractometer and measurement conditions are as follows. Crystal structure analysis was performed using a powder X-ray diffraction device {MiniFlex} manufactured by Rigaku Corporation. The X-ray source used in XRD was a CuKα source {λ = 1.541841 Å (angstrom)}, output was 30 kV / 15 mA, scan speed was 1.0 ° / min, sampling width was 0.01 °, measurement The mode was a continuous condition.

  In addition, when the half value width in d = 2.814 was measured on the same conditions as the said X-ray-diffraction test, Example 2-1 is about 0.5 and Example 2-2 is also about 0.5. there were.

<< Thermogravimetric differential thermal analysis >>
FIGS. 2-1 to 2-2 are the results of thermogravimetric differential thermal analysis (TG-DTA) measurement of the hydroxyapatite fired body particle group according to Example 2-1 and Comparative Example 2-1. As can be seen from the figure, in Example 2-1 (FIG. 2-1), a weight loss of 2% or more with a clear endotherm at 650 ° C. to 800 ° C. was not observed. On the other hand, in Comparative Example 2-1 (FIG. 2-2), a weight loss of 2% or more with a clear endotherm was observed at 650 ° C. to 800 ° C.

  Similarly, Example 2-2 did not observe a weight loss of 2% or more with a clear endotherm between 650 ° C. and 800 ° C., whereas Comparative Examples 2-2 to 2-3 were 650 ° C. A weight loss of 2% or more with a clear endotherm was observed from ˜800 ° C.

  Furthermore, as a moisture adsorption test, after the hydroxyapatite fired body particle group according to Example 2-1 was dried for 18 hours or more under conditions of a temperature of 60 ° C. and a humidity of 45 to 85%, the temperature was 25 ° C. under normal pressure. And a humidity of 50% for 3 days or more, and a thermogravimetric differential thermal analyzer (TG-DTA) (EXSTAR 6000, manufactured by Seiko Instruments Inc.) under a nitrogen stream at 10 ° C./min. When the weight decreased in the temperature range of 25 to 200 ° C. was measured, it was 1.34%. Moreover, when a similar test was performed on Example 2-1, a similar level of result was obtained.

<< FT-IR analysis >>
(About calcium carbonate)
The present inventors examined how the amount of calcium carbonate is changed by the pickling process when producing the hydroxyapatite (HAp) particles of Example 2-1. This is shown in FIG. The left chart in FIG. 2-3 shows hydroxyapatite particles that have not been pickled, and the right chart in FIG. 2-3 shows hydroxyapatite (HAp) particles that have been pickled. In particular, in chart showing the absorbance of calculating the spectrum obtained in the FT-IR measurement in Kubelka-Munk (KM) equation, to separate the peak wavenumber appears between ^{860cm -1 ~890cm} -1, it was evaluated. As a result, it was confirmed that in the hydroxyapatite particles subjected to the pickling process (the right diagram in FIG. 2-3), a peak near 877 cm ⁻¹ attributed to calcium carbonate is not observed. On the other hand, in the hydroxyapatite particles not subjected to the pickling step (the left diagram in FIG. 2-3), a peak near 877 cm ⁻¹ attributed to calcium carbonate was observed.

(About carbonate apatite)
2-4 to 2-5 are FT-IR spectra of hydroxyapatite (HAp) fired particles according to Example 2-1 and Example 2-2. As can be seen from the figure, in Examples 2-1 and 2-2, absorption was observed at 1350 cm ^{−1 to} 1500 cm ⁻¹ . Therefore, it was confirmed that Example 2-1 and Example 2-2 contain carbonate apatite.

<< Consideration based on results of X-ray diffraction test, thermogravimetric differential thermal analysis, and FT-IR analysis >>
From the results of X-ray diffraction test, thermogravimetric differential thermal analysis, and FT-IR analysis, Example 2-1 and Example 2-2 are substantially free of calcium carbonate and contain carbonate apatite. It was.
On the other hand, Comparative Examples 2-1 to 2-3 contain calcium carbonate from the results of thermogravimetric differential thermal analysis.
When producing hydroxyapatite particles, it is considered that calcium carbonate was removed by a pickling process or the like.
Moreover, it is confirmed that Example 2-1 and Example 2-2 contain B-type carbonate apatite.

The FT-IR analyzer and measurement conditions are as follows. A hydroxyapatite (HAp) calcined particle group was taken so as to be 10% by weight with respect to potassium bromide [KBr], and a measurement sample sufficiently ground in an agate mortar was diffusely reflected using FT-IR Spectrum 100 manufactured by PerkinElmer. the range of ^{450cm -1 ~4000cm} -1 at was measured at 8 cumulative. In addition, peak separation was performed by using software called fityk 0.9.4 under the conditions of Function Type: Gaussian and Fitting Method: Levenberg-Marquardt.

  The thermogravimetric differential thermal analysis (TG-DTA) measurement conditions are as follows. Thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR 6000) under a nitrogen stream at 10 ° C./min. The amount of decarboxylation was evaluated from the weight decreased in the temperature range of 700 ° C to 950 ° C.

  In the case of following the method of Patent No. 5044336, a polymer compound having any of a carboxyl group, a sulfate group, a sulfonate group, a phosphate group, a phosphonic acid group, or an amino group in the side chain is used as an anti-fusing agent. Specific compounds include polyacrylic acid, polymethacrylic acid, polyglutamic acid, ethylenesulfonic acid, polymethacrylic acid alkylsulfonic acid ester, polyacryloylaminomethylphosphonic acid, and polypeptide. ing. Referring to Comparative Example 2-1, it can be confirmed that calcium carbonate is produced when such a compound is used. Based on this, the present inventors estimated that the cause of calcium carbonate generation was carbonic acid, which is a decomposition product of the polymer compound used as an anti-fusing agent.

  Further, when the production method of Japanese Patent No. 5043436 is followed, a calcium carbonate film is formed on the surface of the calcined hydroxyapatite particles even when the “component containing a carbonic acid source” is not used as an anti-fusing agent. The present inventors considered the reason as follows.

  According to the description of Japanese Patent No. 5043436, the firing is considered to be performed in an air atmosphere. Here, when a component containing an alkali metal (sodium, potassium) or an alkaline earth metal (calcium) is used as an anti-fusing agent, an alkali metal oxide or an alkaline earth metal oxide is used in the firing process. It is formed. Here, since alkali metal oxides and alkaline earth metal oxides are basic, they neutralize with carbon dioxide in the atmosphere. Furthermore, when an alkali metal salt is used as an anti-fusing agent, calcium and alkali metal constituting the hydroxyapatite crystals are ion-exchanged near the surface of the particles. As a result, calcium carbonate is generated on the surface of hydroxyapatite by a reaction between carbonic acid radicals derived from carbon dioxide in the atmosphere and calcium derived from the anti-fusing agent or calcium generated on the surface by ion exchange.

<< Appearance observation test >>
2-6 and 2-7 are SEM photographs of the hydroxyapatite (HAp) fired particles according to Example 2-1 (difference in scale). From these photographs, it can be seen that the hydroxyapatite (HAp) fired body particle group according to Example 2-1 is a hydroxyapatite fired body particle group including spherical hydroxyapatite (HAp) fired body particles. FIGS. 2-8 and 2-9 are SEM photographs of the hydroxyapatite fired body particle group according to Example 2-2 (difference in scale). From these photographs, it can be seen that the hydroxyapatite (HAp) fired body particle group according to Example 2-1 is a hydroxyapatite (HAp) fired body particle group including rod-like hydroxyapatite fired body particles.

<< Composition Analysis >>
As a result of composition analysis of the ceramic particles according to Examples 2-1 and 2-2,
Ca _x (PO ₄ ) _6-y (CO ₃ ) _y (OH) ₂
(Wherein, x is a number of 8 or more and 12 or less, and y is a number greater than 0 and 3 or less).
The measuring method is as described above.

<< Dispersibility test >>
60 mg of sintered hydroxyapatite (HAp) (sintered hydroxyapatite (HAp) according to Example 2-1 and Comparative Example 2-1) and 3 ml of ethanol were mixed, and the sintered hydroxyapatite dispersed by ultrasonic irradiation for 30 minutes. A liquid was prepared. 200 ml of water was added to a water circulation flow cell of a laser scattering particle size distribution meter (manufactured by Shimadzu Corporation, SALD-7500 nano), and a sintered hydroxyapatite dispersion was dropped so that the intensity of the laser scattered light became the measurement region of the apparatus. The circulation tank was irradiated with ultrasonic waves for 5 minutes, and the particle size distribution was measured. Dispersibility was evaluated by examining the abundance (%) of 500 nm or less in terms of volume from the obtained particle size distribution. The higher the abundance (%) of 500 nm or less, the higher the dispersibility. The results are shown in Table 2-1 below.

  From the above table, it is clear that Example 2-1 exhibits significantly higher dispersibility than Comparative Example 2-1.

  In addition, the variation coefficient of the particle diameter of Example 2-1 was 17%. The particle diameter of Example 2-2 is such that the short axis has a maximum diameter of 51 nm and the long axis is 170 nm, grows in the c-axis direction, and the crystal aspect ratio (c-axis length / a-axis length) is 3. 33.

<< Cell adhesion test >>
<Manufacture of test materials>
(Cleaning process)
A circular polyethylene terephthalate (PET) sheet (diameter 9 mm, thickness 0.1 mm) was subjected to alcohol treatment (ultrasonic irradiation for 5 minutes in alcohol (ethanol, 2-propanol, etc.)).

(Linker introduction process)
Corona discharge treatment (100 V, 15 seconds on one side) was applied to both surfaces of the PET sheet that had been subjected to the cleaning treatment. A PET sheet after corona discharge treatment and 10 ml of acrylic acid (manufactured by Wako Pure Chemical Industries, Ltd.) were placed in a 20 ml test tube, and the inside of the test tube was depressurized with a vacuum pump to perform a deaeration operation. The test tube was sealed under reduced pressure, and graft polymerization was performed in a water bath at a temperature of 60 ° C. for 60 minutes. After the treatment, in order to remove the acrylic acid homopolymer adhering to the substrate surface, the mixture was stirred in water at room temperature for 60 minutes, and then the substrate surface was washed with water and then with ethanol.

(Sintered hydroxyapatite (HAp) fine particle immobilization treatment)
After the treatment, the base material is dispersed with 1% sintered hydroxyapatite (HAp) fine particles (sintered hydroxyapatite (HAp) fine particles according to Example 2-1, Example 2-2, and Comparative Example 2-1). The mixture was allowed to stand at 20 ° C. for 30 minutes in a liquid (dispersion medium: ethanol). Then, ultrasonic irradiation was performed for 5 minutes, the base material was taken out and dried at 20 ° C. and normal pressure to obtain a test material.

<Evaluation of cell adhesion and cell morphology>
Cell adhesion and cell morphology evaluation tests were performed using the prepared test materials. Prior to the test, the test material was washed with ethanol, washed with phosphate buffered saline (PBS) and medium (MEM α (serum-free)) (3 times), then immersed in the medium and incubated until use. (37 ° C., 5% CO ₂ ). And cell culture was implemented in the following procedures. First, a culture medium (200 μL / hole) and a test material (test sheet) were placed in a 48-well plate. Thereafter, a suspension of osteoblast-like cells (MC3T3-E1 (subclone 14)) was added (about 1 × 10 ⁵ cells / 200 μL / well) and cultured for 3 hours.

(Cell observation)
FIGS. 2-10 to 2-12 are specimens manufactured using hydroxyapatite (HAp) sintered particles according to Example 2-1, Example 2-2, and Comparative Example 2-1, respectively. It is a SEM photograph of material. Based on the photograph, the state of cell aggregation, cell morphology, and cell density were determined. The results are shown in Table 2. As for the cell density, the greater the number of “+”, the higher the cell density. Moreover, the average coverage of each test material is calculated from SEM photographs.

  As can be seen from FIGS. 2-10 to 2-12 and Table 2-2, when the hydroxyapatite sintered particles according to Example 2-1 and Example 2-2 are used, excellent cell adhesiveness is exhibited. It was also confirmed that most cells showed a greatly expanded cell morphology. On the other hand, when the hydroxyapatite sintered body particle group according to Comparative Example 2-1 was used, it was confirmed that the cell adhesiveness was inferior.

(Manufacture and evaluation of implants)
According to the method described in the examples of the pamphlet of WO2010 / 125686, the above-described ceramic particles (ceramic particles according to Examples 1-1, 1-2, 2-1, and 2-2) are used as a base material (titanium). Combined to obtain an implant. As a result of conducting a cell adhesion test and a foaming test on the implant, a more excellent effect was confirmed in comparison with the conventional ceramic particles. Further, as mentioned above, since calcium carbonate is substantially absent, there is a concern that biocompatibility is reduced and solubility is increased due to the high pH due to the presence of calcium carbonate. Lower than the complex.

Claims (8)

In a medical implant carrying ceramic particles at least partially,
The particle size of the ceramic particles is in the range of 10 nm to 700 nm,
The ceramic particles are calcium phosphate sintered particles,
The medical implant, wherein the ceramic particles do not contain calcium carbonate.   The medical implant according to claim 1, wherein the ceramic particles are spherical. In a medical implant carrying ceramic particles at least partially,
The ceramic particles have a minor axis maximum diameter of 30 nm to 5 μm and a major axis of 75 nm to 10 μm, grow in the c-axis direction, and have an aspect ratio (c-axis length / a-axis length) of 1 ~ 30,
The ceramic particles are calcium phosphate sintered particles,
The medical implant, wherein the ceramic particles do not contain calcium carbonate.   The medical implant according to any one of claims 1 to 3, wherein the ceramic particles are hydroxyapatite sintered particles.   The medical implant according to any one of claims 1 to 4, wherein the ceramic particles do not contain an alkali metal element.   The medical implant according to any one of claims 1 to 5, wherein the ceramic particles include carbonate apatite at least on a surface thereof. The medical implant according to any one of claims 1 to 6, wherein the ceramic particles satisfy the following property (A).
(A) After sufficiently drying, after being left for 3 days or more under conditions of atmospheric pressure, temperature 25 ° C., humidity 50%, thermogravimetric differential thermal analyzer (TG-DTA) (manufactured by Seiko Instruments Inc., EXSTAR 6000) under a nitrogen stream at 10 ° C./min. The weight decreased in the temperature range of 25 to 200 ° C. is 2% or less.   The medical particles according to any one of claims 1 to 7, wherein the ceramic particles have a half width at d = 2.814 measured by an X-ray diffraction method in a range of 0.2 to 0.8. Implant.